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Abstract 
Schizophrenia is an extremely debilitating psychiatric disorder that causes a drastic reduction 
in quality of life and strong impairments in social and occupational functioning. Patients with 
schizophrenia experience a broad spectrum of symptoms, among others, apathy and 
diminished expression (called negative symptoms) as well as delusions, hallucinations, and 
disorganized thoughts (called positive symptoms). The current understanding of the etiology 
of schizophrenia is a multifactorial model, with the factors genetics, neurodevelopment and 
environment. With regard to neurochemical abnormalities, a dysregulation in the 
dopaminergic system is proposed as primary pathology. The dopamine hypothesis of 
schizophrenia suggests that positive symptoms are linked to an excess of dopamine in the 
mesolimbic system, and negative symptoms are linked to a hypodopaminergic function in the 
mesocortical system (Kapur, 2003).  
 
Dopamine also plays a pivotal role in reward processing. Recent evidence suggests that 
particularly learning and wanting, which are proposed as two out of the three main behavioral 
functions of reward, are mainly mediated by dopamine. The behavioral function of wanting 
implies that rewards serve as motivational magnets that attract us, lead to approach behavior 
and let us invest additional effort. The function learning implies that rewards induce changes 
in observable behavior and serve as positive reinforcers by increasing the frequency of 
behavior associated with the receipt of a reward. The evidence of dopamine’s role in wanting 
and learning, combined with its implication in the etiology of schizophrenia, led to increased 
interest in studying the symptomatology of schizophrenia within a reward processing 
framework. The aim of this dissertation is to contribute to this effort by further elucidating how 
disturbances in specific reward processes relate to the pathophysiology and symptomatology 
of schizophrenia.  
 
In study 1 (chapter 2.1. & appendix A) we are clarifying the specific associations of the two 
negative symptom factors apathy and diminished expression with deficits in reward 
anticipation, which is considered a subcomponent of wanting. To operationalize reward 
anticipation, we applied a variant of the monetary incentive delay task where rewards are not 
probabilistic, but dependent on the subjects’ individual performance. We argue that this 
operationalization serves better to simulate goal-directed behavior. For the first time we could 
show that ventral striatal activity, which plays a pivotal role in reward anticipation, is inversely 
correlated with apathy, but not with diminished expression. This correlation implies that 
apathy reflects – among other factors – reduced wanting of a reward, which leads to a 
reduction in approach behavior and hence, reduced goal-directed behavior. Furthermore, the 
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specific correlation of ventral striatal activity during reward anticipation with apathy supports 
the notion that the two negative symptom factors have specific underlying neurobiological 
mechanisms.  
 
In the second study (chapter 2.2 & appendix B), we are elucidating a tonic form of reward 
anticipation, i.e., how the prospect of a reward modulates behavior during an extended 
period of time. We were particularly interested in how incentives change cognitive 
performance since the acquisition of most rewards in everyday life depend on the investment 
of cognitive effort. Although negative symptoms have been implicated with deficits in reward 
anticipation and cognition, no study ever elucidated the interaction between the two domains 
on a neurobiological level. We applied a well-known working memory task and varied the 
incentive for performance. When cognitive effort was rewarded compared to when it was not 
rewarded, we found – among other regions – activity in the rostral anterior cingulate (ACC). 
The ACC is considered to act as a hub region that links motivation and cognition, thereby 
controlling the demand of processing resources. We did not find any significant group 
difference between patients and healthy controls, which indicates that these groups do not 
differ in how they integrate information about prospective rewards and how they utilize this 
information in order to increase their performance. However, we found that the enhanced 
ACC activity in patients is inversely correlated with the negative symptom factor diminished 
expression. This is in line with the cognitive resource limitations model of diminished 
expression proposed by Cohen (2012). However, we expand Cohen’s model by arguing that 
diminished expression is not solely caused by limited cognitive resources, but also by the 
inappropriate modulation of these resources. Additionally, we are the first group to propose a 
potential neurobiological model of diminished expression. 
 
In the third study (chapter 2.3 & appendix C), we are elucidating whether patients with 
schizophrenia show deficits in reward representations. Since most representations of 
rewards are not inherent, they have to be learned at first. Hence, the representation of 
rewards can be considered the result of a learning process. A crucial mechanism for 
encoding rewards is the context specific adaptation of neural sensitivity. In order to encode 
an unlimited number of rewards with a limited number of neurons, neurons adapt their firing 
range to the currently available rewards in the environment. This ensures that reward 
sensitive neurons always exploit their entire firing range, which guarantees optimal 
discriminability between different reward amounts and hence, an accurate and precise 
representation of reward information. Although various studies have implied that deficits in 
reward representations could be the cause of reinforcement learning deficits, alterations in 
effort-cost computation, or deficits in associative learning, no study ever elucidated adaptive 
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coding in patients with schizophrenia. For the first time, we show that patients with 
schizophrenia have deficits in the adaptation of neural sensitivity to the current reward 
context, which suggests that their reward representations are imprecise. We argue that this 
deficit could lie at the root of many dysfunctional reward processes, since an accurate 
representation is a prerequisite for any process that includes reward information. 
Furthermore, we provide evidence that this deficit is related to the general symptom severity, 
which suggests that this deficit could reflect a more basic dysfunction of schizophrenia 
instead of a specific symptom correlate.  
 
In sum, we found evidence that specific reward-related processes, i.e., tonic and phasic 
forms of reward anticipation and adaptive coding of reward information, are correlated with 
symptoms of schizophrenia. This shows that abnormalities in reward processes, which are all 
mediated by dopamine, have the potential to offer insight into the symptomatology and the 
underlying neurobiology of schizophrenia. This holds promise for developing more targeted 
and efficient treatments. The results of this dissertation also support the increased effort in 
using reward processing as a transdiagnostic framework for studying hedonic deficits, 
motivational impairments, and learning deficits in other psychopathological disorders, such 
as major depression and bipolar disorder. 
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Zusammenfassung 
Die Schizophrenie ist eine extreme beeinträchtigende psychische Krankheit, die eine 
drastische Reduktion der Lebensqualität und eine starke Einschränkung des Sozial- und 
Berufslebens zur Folge hat. Patienten mit einer Schizophrenie leiden unter einem breiten 
Spektrum an Symptomen, unter anderem an Apathie und reduziertem Ausdruck (genannt 
Negativsymptome) sowie an Halluzinationen, Wahnvorstellungen, und Denkstörungen 
(genannt Positivsymptome). Das aktuelle Verständnis der Ätiologie der Schizophrenie basiert 
auf einem multifaktoriellen Modell mit den Faktoren Genetik, neuronale Entwicklung und 
Umwelt. In Bezug auf neurochemische Abnormitäten wird eine Dysregulation des 
dopaminergen Systems als primäre Pathologie propagiert. Die Dopaminhyopthese der 
Schizophrenie legt nahe, dass Positivsymptome durch einen Exzess an Dopamin im 
mesolimbischen System verursacht werden, während dem Negativsymptome auf einer 
hypodopaminergen Funktion des mesocorticalen Systems basieren.  
 
Dopamin spielt auch bei der Verarbeitung von Belohnung eine entscheidende Rolle. Neuere 
Beweise gehen davon aus, dass insbesondere Lernen und Wollen, welche als zwei der drei 
Hauptverhaltensfunktionen von Belohnung gelten, stark durch Dopamin moduliert werden. 
Die Funktion Wollen wiederspiegelt, dass Belohnungen motivationale Magnete sind, die uns 
anziehen, Annäherungsverhalten auslösen und uns zusätzliche Anstrengungen investieren 
lassen. Die Lernfunktion bedeutet, dass Belohnungen beobachtbare Verhaltensänderungen 
herbeiführen und Verhalten positiv verstärken, das in einer Belohnung mündet. Die 
Erkenntnis, das Dopamin im Wollen und Lernen eine wichtige Rolle spielt, kombiniert mit der 
ätiologischen Bedeutung Dopamins in der Schizophrenie, haben zu einer Zunahme des 
Interesses geführt, die Symptomatik der Schizophrenie im Rahmen der 
Belohnungsverarbeitung zu betrachten. Ziel dieser Dissertation ist es, diese Bemühungen zu 
unterstützen und genauer zu untersuchen, in welchem Zusammenhang spezifische 
Störungen in der Belohnungsverarbeitung mit der Pathophysiologie und Symptomatik der 
Schizophrenie stehen. 
 
In Studie eins (Kapitel 2.1 & Appendix A) verdeutlichen wir den spezifischen Zusammenhang 
der beiden Negativsymptomfaktoren Apathie und reduzierter Ausdruck mit Defiziten in der 
Belohnungsantizipation, welches eine Subkomponente des Wollens ist. Um die 
Belohnungsantizipation zu operationalisieren haben wir eine Variante der Monetary Incentive 
Delay Aufgabe verwendet, in welcher die Belohnung nicht probabilistisch ist, sondern vom 
individuellen Verhalten der Teilnehmer abhängt. Wir glauben, dass diese Operationalisierung 
besser dazu dient, zielgerichtetes Verhalten zu simulieren. Wir zeigen zum ersten Mal, dass 
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die Aktivität im ventralen Striatum, welches bei der Antizipation von Belohnung eine 
entscheidende Rolle spielt, invers mit dem Faktor Apathie korreliert, und nicht mit dem 
Faktor reduziertes Verhalten. Diese Korrelation legt nahe, dass Apathie – unter anderem – 
auf ein reduziertes Wollen einer Belohnung zurückzuführen ist, welches zu einer Reduktion 
von Annäherungsverhalten und zielgerichtetem Verhalten führt. Zudem unterstützt die 
spezifische Korrelation der Aktivität im ventralen Striatum während der 
Belohnungsantizipation mit dem Faktor Apathie die Idee, dass den beiden 
Negativsymptomfaktoren unterschiedliche neurobiologische Mechanismen zugrunde liegen.  
 
In der zweiten Studie (Kapitel 2.2 & Appendix B) untersuchen wir eine tonische Form der 
Belohnungsantizipation, das heisst, wie der Ausblick eine Belohnung zu erhalten ein 
Verhalten über eine längeren Zeitraum moduliert. Wir waren spezifisch daran interessiert, 
wie Anreize die kognitive Leistung verändern, da die Akquirierung der meisten Belohnungen 
im Alltag vom Einsatz kognitiver Bemühungen abhängen. Obwohl Negativsymptome mit 
Defiziten in der Belohnungsantizipation und der Kognition in Verbindung gebracht wurden, 
hat keine Studie je die neurobiologische Basis der Interaktion zwischen diesen beiden 
Domänen untersucht. Wir verwendeten eine bekannte Arbeitsgedächtnisaufgabe und 
variierten die Belohnung für die Leistung. Neben anderen Regionen fanden wir Aktivität im 
rostralen anterioren Cingulum, welches als Drehkreuzregion betrachtet wird, die Motivation 
und Kognition miteinander verbindet und die Nachfrage nach Ressourcen reguliert. Wir 
fanden keine signifikanten Gruppenunterschiede zwischen Patienten und gesunden 
Kontrollen, was indiziert, dass sich diese beiden Gruppen nicht darin unterscheiden, wie sie 
Belohnungsinformation zu integrieren und wie sie diese dazu nutzen, die kognitive 
Leistungsfähigkeit zu steigern. Wir haben jedoch entdeckt, dass die Aktivität im anterioren 
Cingulum negativ mit dem Negativfaktor reduzierter Ausdruck korreliert. Dies ist 
grundsätzlich in Übereinstimmung mit der Theorie der limitierten kognitive Ressourcen von 
Cohen (2012). Allerdings erweitern wir das Modell Cohens indem wir vorschlagen, dass 
reduzierter Ausdruck nicht bloss durch limitierte kognitive Ressourcen entsteht, sondern 
auch durch eine inadäquate Modulation der verfügbaren Ressourcen. Zudem liefern wir als 
erste Gruppe ein mögliches neurobiologisches Modell des reduzierten Ausdrucks. 
 
In der dritten Studie (Kapitel 2.3 & Appendix C) untersuchen wir ob Patienten mit einer 
Schizophrenie Defizite in der Belohnungsrepräsentation haben. Da die meisten 
Belohnungsrepräsentationen nicht angeboren sind, müssen sie zuerst gelernt werden. 
Deshalb kann man die Repräsentation von Belohnungen als Ergebnis eines Lernprozesses 
betrachtet werden. Ein wesentlicher Mechanismus der Encodierung von Belohnungen ist die 
kontextspezifische Adaptation der neuronalen Sensitivität. Um eine theoretisch unlimitierte 
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Menge an Belohnungen mit einer limitierten Menge an Neuronen zu encodieren, passen die 
Neurone ihre Feuerungssensitivität den momentan verfügbaren Belohnungen in der 
Umgebung an. Dies garantiert, dass belohnungssensitive Neurone immer die ganze 
Bandbreite ihrer möglichen Feuerungsrate ausnutzen, was eine optimale Diskriminierung 
zwischen verschiedenen Belohnungsstufen ermöglicht. Obwohl verschiedenste Studien 
bereits angedeutet haben, dass Defizite in der Belohnungsrepräsentation mit ein Grund für 
Defizite im Verstärkungslernen, der Kosten-Nuten-Berechnung oder Defizite im assoziativen 
Lernen sein könnten, hat noch keine Studie je das adaptive Codieren von Belohnungen 
untersucht. Wir zeigen zum ersten Mal, dass Patienten mit einer Schizophrenie solche 
Defizite aufweisen, was dafür spricht, dass sie Belohnungen unpräzise repräsentieren. Wir 
glauben, dass dieses Defizit die Grundlage für viele dysfunktionale Belohnungs-
verarbeitungsprozesse darstellen könnte, da eine akkurate Repräsentation eine wichtig 
Voraussetzung für alle Prozesse der Belohnungsverarbeitung ist. Zudem liefern wir Beweise, 
dass dieses Defizit mit der generellen Symptomschwere zusammenhängt, was nahelegt, 
dass es sich bei diesem Defizit um eine basale Dysfunktion der Schizophrenie handeln 
könnte. 
 
Zusammenfassend habe wir Beweise dafür gefunden, dass spezifische Prozesse der 
Belohnungsverarbeitung, wie die phasische und tonische Belohnungsantizipation und das 
adaptive Codieren von Belohnungsinformation, mit den Symptomen der Schizophrenie 
zusammenhängen. Das zeigt, dass Abnormitäten in spezifischen Belohnungsverarbeitungs-
prozessen, welche alle durch Dopamin beeinflusst werden, das Potential haben, 
Erkenntnisse über die Symptomatik und die zugrundeliegenden neurobiologischen 
Mechanismen zu liefern. Dies nährt die Hoffnung auf spezifischere und effizientere 
Behandlungen. Die Resultate dieser Dissertation unterstützen auch die gestiegenen 
Bemühungen, Defizite in der Belohnungsverarbeitung als transdiagnostischen Rahmen für 
die Untersuchung von motivationalen Einschränkungen und Lerndefiziten in anderen 
psychiatrischen Erkrankungen, wie zum Beispiel der unipolaren und bipolaren Depression, 
zu nutzen.  
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1.1. Schizophrenia and its symptoms 
Schizophrenia is one of the most debilitating mental disorders, severely impairing individuals’ 
social and occupational functioning as well as quality of life (Mueser & McGurk, 2004; S. K. 
Schultz & Andreasen, 1999). The prevalence of schizophrenia is about 1% across cultures, 
with men being slightly more affected than women (1.4:1) (Aleman, Kahn, & Selten, 2003; 
McGrath, Saha, Chant, & Welham, 2008). Furthermore, men tend to have an onset between 
the ages of 15 to 25, whereas women tend to have an age of onset between 25 and 35. This 
is proposed as one of the factors that contributes to a more severe disease course in men 
compared to women, since the later onset in women is associated with a better social 
development and functioning before the start of the illness (Angermeyer, Kühn, & Goldstein, 
1990; Häfner, 2000). Besides affecting mental health, patients with schizophrenia die 12 – 15 
years before the average population, thereby causing more loss of lives than most cancers 
and physical illnesses (Saha, Chant, & McGrath, 2007).  
 
The term schizophrenia does not refer to a single disease with a specific course, but rather to 
a complex disease spectrum with diverse clinical presentations and treatment responses 
across individuals (Heckers et al., 2013; Tandon et al., 2013). Symptoms characterizing 
schizophrenia can be grouped into five symptom domains: 1) hallucinations, 2) delusions, 3) 
disorganized thought (speech), 4) disorganized or abnormal motor behavior (including 
catatonia), and 5) negative symptoms (Heckers et al., 2013; van Os & Kapur, 2009). 
According to the DSM-5 diagnostic criteria, at least one positive symptom (delusions, 
hallucinations, disorganized thoughts), and a total of at least two symptoms have to be 
present for a significant portion of time during a one-month period within a total duration of 
illness of six month (APA, 2013). Furthermore, a substantial deterioration of social and 
occupational functioning is required to fulfill the diagnostic criteria of schizophrenia. Apart of 
these classical psychopathological domains that are based on a categorical assessment of 
schizophrenia, models with an underlying dimensional structure have been proposed 
(Heckers et al., 2013; van Os & Kapur, 2009). Analyses of the psychopathological features 
revealed that symptoms can be grouped into five dimensions: a positive-symptom dimension 
(including delusions, hallucinations, disorganized thoughts), a negative-symptom dimension 
(including avolition, anhedonia, social withdrawal, blunted affect and alogia), a cognitive-
symptom dimension (reflecting alterations in neurocognition such as attention deficits, 
impairments in memory and executive functioning), and two affective dimensions, i.e., 
depressive symptoms and manic symptoms (see Figure 1) (van Os & Kapur, 2009). 
Importantly, dimensional approaches are proposed to be more useful at predicting clinical 
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course and treatment needs in comparison to traditional categorical diagnostic criteria 
(Allardyce, Gaebel, Zielasek, & van Os, 2007). 
 
In the last decades, much effort has been invested to elucidate the underlying 
pathophysiology of distinct subdomains of these symptom dimensions. A lot of research has 
especially focused on the structure of negative symptoms since treatment responsiveness of 
current pharmacological therapies is negligible (Erhart, Marder, & Carpenter, 2006). There is 
now consensus that the five negative symptoms avolition, anhedonia, social withdrawal, 
blunted affect and alogia can be group into two factors: 1) apathy, consisting of avolition, 
anhedonia, as well as social withdrawal, and 2) diminished expression, consisting of blunted 
affect and alogia (Blanchard & Cohen, 2006; Foussias & Remington, 2010; Messinger et al., 
2011; Strauss et al., 2012).  
 
The current understanding of the etiology of schizophrenia is a multifactorial model that 
unites various factors, such as genetics, neurodevelopment, and environment. With regard to 
neurochemical abnormalities, the dopamine circuitry has been postulated as primary 
pathology for more than 50 years (Carlsson & Lindqvist, 1963; van Rossum, 1966). The 
theory posits that positive and negative symptoms are – among other factors – the result of a 
dysbalanced dopamine release in cortical and subcortical regions. Whereas positive 
symptoms are attributed to an excess of dopamine in the mesolimbic system (resulting in the 
attribution of aberrant salience to irrelevant stimuli), negative symptoms are linked to a 
hypodopaminergic function in the mesocortical system (which leads to a failure in 
appropriately responding to meaningful reward cues) (Kapur, 2003).  
 
 
 
Figure 1. Symptom dimensions of schizophrenia (adapted from van Os & Kapur, 2009) 
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1.2. Reward processing 
Rewards are crucial for survival and reproduction. Ultimately, they are responsible that 
organisms engage in their most basic behaviors: eating, drinking, and mating. The impacts of 
rewards range from the control of vegetative states to the organization of goal-directed 
behavior (McClure, York, & Montague, 2004; W. Schultz, 2000; Wolfram Schultz, 2015). 
According to Wolfram Schultz (2015), the acquisition of reward is so critical for survival and 
procreation that rewards might even be the reason why brains evolved in multicellular 
organisms. Because reward acquisition is so essential, organisms able to acquire more of 
them have an evolutionary advantage. Hence, throughout evolution, brains were optimized to 
process rewards by enabling organisms to learn about them, to identify and seek them, and 
to acquire them through decisions and actions. 
 
The evolutionary importance of reward processing stimulated great research interest. 
However, since our brain is not equipped with specific reward receptors, we cannot 
investigate reward processing by simply looking at specific properties of such receptors. We 
see, feel, taste and smell rewarding stimuli with the same sensory systems as non-rewarding 
stimuli. Furthermore, rewards do not carry special physical properties, which makes it 
impossible to recognize them via specific markers. Instead, what makes rewards unique is 
the behavioral reaction they elicit. Therefore, behavioral theories that provide concepts of 
reward functions are crucial for investigating reward processing (Berridge & Robinson, 2003; 
Berridge, Robinson, & Aldridge, 2009; W. Schultz, 2000; Wolfram Schultz, 2015). Currently, 
three major, closely interwoven reward functions (with further subdivisions and levels) are 
propagated (Berridge et al., 2009; Wolfram Schultz, 2015): 
 
1. liking/positive emotions* 
Rewards can elicit positive emotions, above all, the experience of pleasure.  
 
2. wanting/approach behavior* 
Rewards serve as motivational magnets, they attract us, lead to approach behavior 
and let us invest additional effort.  
 
3. learning 
Rewards may elicit a learning process. We associate and predict rewards based on 
past experience. Learning can be implicit or explicit and the products of learning can 
be declarative or procedural. 																																																								*„liking“ and „pleasure“ as well as „wanting“ and „approach behavior“ are used 
interchangeably here. 
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Although there are no specific reward receptors, evidence supports the notion that partly 
dissociable brain circuits are particularly sensitive to reward and mediate the three different 
functions of reward. However, the identification of separate brain substrates remains a major 
challenge since rewarding stimuli elicit many or all of these reward components 
simultaneously and hence, activate all involved brain regions at the same time (Berridge & 
Kringelbach, 2008). That the brain circuits involved in the functions of liking, wanting, and 
learning are interconnected is also a necessity since these three functions need to interact in 
order to serve their ultimate purpose: survival and procreation. However, for a better 
understanding of reward processing it is important to tease apart the activity induced by a 
reward and relate it to the according functions.  
 
Particularly liking has been associated with a separable brain circuit compared to wanting 
and learning. It is assumed that the opioid, cannabinoid and GABA-benzodiazepine 
neurotransmitter systems is involved in the experience of pleasure. ‘Hedonic hotspots’ in the 
limbic system, specifically in the shell of the nucleus accumbens and the ventral tegmentum 
have been found to enhance pleasure reactions (Kringelbach & Berridge, 2009). Wanting 
and learning on the other hand are mainly associated with the dopaminergic system. 
However, the differentiation of these two reward components is less clear. Both functions 
have been associated with activity in mesocorticolimbic and mesostriatal dopamine neurons, 
including their widespread projections to cortical and subcortical structures, such as the 
striatum, the anterior cingulate, the insula and the prefrontal cortex (Berridge et al., 2009; W. 
Schultz, 2000; Wolfram Schultz, 2013; Ziauddeen & Murray, 2010). 
 
 
 
 
Figure 2. Major functions of rewards and their psychological components (adapted from 
Berridge et al., 2009 and Wolfram Schultz, 2015) 
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1.3. Reward processing deficits in schizophrenia 
With the proposition of sophisticated behavioral theories of reward functions and their 
underlying neurobiological substrates, evidence of reward processing abnormalities in 
patients with schizophrenia accumulated. Positive symptoms have been found to correlate 
with dysfunctional learning mechanisms, and negative symptoms have been associated with 
deficits in all three components of reward.  
 
Early studies proposed the very intuitive theory that negative symptoms originate from 
diminished hedonic responses. It was thought that patients do not engage in goal-directed 
behavior because they simply do not experience pleasure when they perform such activities. 
Additionally, a numbing or lack of hedonic experience would also help to explain diminished 
expressive behavior and flattened affect. However, accumulated evidence suggests that this 
is not the case: patients with schizophrenia report similar levels of positive emotions and 
show comparable brain activity to healthy controls when confronted with an emotionally 
evocative stimulus. Hence, a lack in the experience of positive emotions cannot explain why 
patients with schizophrenia show reduced goal-directed behavior and diminished expression 
(Berridge & Kringelbach, 2008; Gold, Waltz, Prentice, Morris, & Heerey, 2008; Strauss, 
Waltz, & Gold, 2013).  
 
Another possibility that could explain the emergence of negative symptoms despite intact 
hedonic responses is a deficit in wanting. Although one might think that liking and approach 
behavior are related or even identical, i.e., most rewards that are liked are also approached, 
these two reward functions are in fact dissociable on a psychological and neurobiological 
level (see chapter 1.1 & 1.2). Therefore, although a stimulus might evoke positive emotions 
when encountered or consumed, it does not necessarily induce approach behavior in the 
future. Hence, an explanation for the reduced goal directed behavior could be a diminished 
wanting of a reward: a patient might like a reward, but he might not feel attracted to it and 
hence, won’t approach it. In very severe cases, this deficit could explain apathetic behavior, 
as presented in patients with schizophrenia (Strauss et al., 2013). Various studies have 
investigated approach behavior in schizophrenia with the monetary incentive delay (MID) 
task developed by Knutson, Fong, Adams, Varner, & Hommer (2001). The task is based on 
an instrumental conditioning task applied in animal studies and allows elucidating different 
stages of reward processing, in particular reward anticipation, which is one important 
component of wanting (Arias-Carrión & Pŏppel, 2007; B. Knutson, Fong, et al., 2001; Brian 
Knutson & Heinz, 2015; Wolfram Schultz, 2015). The MID task consists of various trials that 
start with the announcement of a (variable) incentive – symbolized by a cue – which is linked 
(with a certain contingency) to the receipt of this incentive. To receive the financial incentive, 
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participants have to correctly react to a target stimulus, which is presented after the reward-
inducing cue. On the neural level, there is consistent evidence that the ventral striatum (VS) 
plays a crucial role in anticipating rewards (B. Knutson, Adams, Fong, & Hommer, 2001; 
Sescousse, Caldú, Segura, & Dreher, 2013). Several research groups reported that patients 
with schizophrenia show diminished VS activity during reward anticipation (Grimm et al., 
2014; Juckel et al., 2006; R. W. Morris et al., 2012; Nielsen et al., 2012; Schlagenhauf et al., 
2008; Simon et al., 2010). Additionally, a few studies linked this (hypo-)activation of the VS to 
negative symptoms, or the factor apathy (Simon et al., 2010; Waltz et al., 2010). However, 
no clear distinction between neurobiological correlates of the two negative symptom 
dimensions apathy and diminished expression has been shown. A specific correlation of 
reward anticipation deficits (as expressed in a reduced VS activation) with apathy would not 
only support the theory of a two factor solution of negative symptoms, but also offer insight 
into the underlying behavioral mechanism and neurobiology of apathy.   
 
Whereas the MID task allows investigating short term, phasic effects of reward anticipation, 
many real life situations require the maintenance of reward information for longer periods of 
time. Additionally, the required action to obtain the reward is often complex and involves the 
investment of cognitive effort. Hence, the acquisition of rewards in everyday life requires a 
translation of reward information into goal representations and a modulation of behavior for 
an extended period of time. Various studies elucidated this process in healthy controls, 
showing that the prospect of a reward enhances cognitive performance and leads to 
additional activity in sensory and cognitive areas (Beck, Locke, Savine, Jimura, & Braver, 
2010; Kennerley & Wallis, 2009; Krawczyk, Gazzaley, & D’Esposito, 2007; Rowe, Eckstein, 
Braver, & Owen, 2008). A proposed mechanism that leads to a better performance when a 
reward is at stake is the prioritization of the process required to obtain the reward. This idea 
is based on the notion that our brain has limited perceptual capacities. Stimuli within our 
environment are constantly competing for perceptual resources and control of behavior. High 
rewards are treated with priority and receive additional resources that are either activated or 
reallocated (Pessoa, 2009). On the neural level, the anterior cingulate cortex is suggested to 
play an essential role in controlling the distribution of resources and in behavioral adaptation. 
It acts as a hub and links reward related structures – such as the ventral striatum – with brain 
structures involved in cognition – such as the lateral prefrontal cortex (Krebs, Boehler, 
Roberts, Song, & Woldorff, 2012; Pessoa, 2008, 2009; Pessoa & Engelmann, 2010; 
Vassena et al., 2014). With regard to negative symptoms in schizophrenia, there is mixed 
evidence of improved performance due to reward anticipation. Whereas various studies 
found no effect of reward on performance, others found an improvement (Barch, Pagliaccio, 
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& Luking, 2015). However, up to today, there are no published fMRI studies examining the 
interaction of reward and cognition in schizophrenia.  
 
Besides the reported deficits in subcomponents of wanting, schizophrenia has been 
associated with deficits in various components of learning, e.g., negative symptoms have 
been linked to deficient reinforcement learning, and positive symptoms have been associated 
with aberrant salience coding (Corlett et al., 2007; Deserno, Boehme, Heinz, & 
Schlagenhauf, 2013; Gold JM, Waltz JA, Matveeva TM, & et al, 2012; R. Morris, Griffiths, 
Pelley, & Weickert, 2013; Murray et al., 2007, 2008; Strauss et al., 2011; Waltz & Gold, 
2007). Learning is an extremely critical function since most representations of rewards as 
well as relationships between rewarding stimuli and actions are not inherent, and hence, 
have to be learned first. Furthermore, due to the changes of internal and external states, 
these representations and associations have to be constantly updated (Berridge et al., 2009; 
Wolfram Schultz, 2015). An accurate representation of reward is crucial and can be seen as 
a prerequisite to choose the optimal action (Tobler, Fiorillo, & Schultz, 2005). A major 
challenge in reward representation is the theoretically unlimited number of rewards that have 
to be encoded by a limited number of reward sensitive neurons. Recent evidence suggests 
that the brain solves this problem by adjusting the neural sensitivity to the currently available 
rewards, a mechanism called adaptive coding of rewards (Cox & Kable, 2014; Kobayashi, 
Carvalho, & Schultz, 2010; Park et al., 2012; Tobler et al., 2005). This adaptation is 
necessary to ensure optimal discriminability of rewards. Hence, a failure in this adaptation 
leads to imprecise representations, which could potentially affect all reward-related 
processes and result in detrimental decision-making. Although it has been suggested that 
patients with schizophrenia have a compromised ability to represent rewards, no study has 
ever elucidated dynamic neural representation of rewards in schizophrenia (Gold JM et al., 
2012; Gold et al., 2008).  
 
 
1.4. Research objectives 
The aim of this dissertation is to fill the research gaps mentioned in chapter 1.3 and to further 
elucidate reward processing deficits and their relation to distinct symptoms in schizophrenia. 
The focus of study 1 and study 2 was to elucidate deficits regarding motivational aspects of 
reward and their relation to negative symptoms. Study 3 was implemented to investigate 
deficits in reward learning and their link to the symptomatology in general (see Figure 3). 
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The aim of study 1 was very specific: clarifying the relation of the two negative symptoms 
factors apathy and diminished expression with regard to the anticipation of reward. In 
contrast to most studies elucidating reward anticipation, we applied a modified version of the 
MID task where rewards are not probabilistic, but dependent on individual performance. We 
believe that this version better operationalizes goal-directed behavior and is therefore better 
aimed to elucidate the relation with the factor apathy. Our hypothesis for study 1 was that the 
activity in the ventral striatum during reward anticipation was specifically correlated with 
apathy, but not with diminished expression. 
 
In study 2, we investigated another component of wanting. Compared to study 1, we 
elucidated tonic reward anticipation effects and their impact on cognitive performance. We 
were interested whether patients with schizophrenia are able to translate reward information 
into goal representations, maintain this information for an extended period of time and 
modulate their behavior accordingly. Importantly, we wanted to specifically elucidate the 
effects of anticipated rewards on cognitive performance since the acquisition of rewards in 
everyday life is mainly achieved through cognitive effort. We applied a well-known working 
memory task and varied the incentive for performance. We chose to model the task with a 
block design because it allows a better investigation of tonic reward effects, since 
participants need to maintain the reward information for a longer period of time. We 
hypothesized that patients with schizophrenia would not profit as much as healthy controls 
from a modulation of cognitive performance with reward. Furthermore, we thought the 
modulation would be correlated with negative symptom severity. On the neural level, we 
expected that patients would show lower ACC activity and a correlation of that activity with 
negative symptoms. 
 
In study 3 we aimed to investigate the neural representations of rewards. Recent evidence 
suggests that these representations are context specific and adjust to the currently available 
rewards in the environment. Although some studies reported that reward representations are 
deficient in schizophrenia, no study ever elucidated adaptive coding of reward in 
schizophrenia. To analyze adaptive reward coding, we focused the analysis of the MID task 
on the outcome phase under two different reward contexts. We hypothesized that patients 
with schizophrenia show deficits in adaptive reward coding and assumed that these deficits 
are related to the symptomatology. 
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Figure 3. Overview of the conducted studies and their relation to the major functions of 
reward. 
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2. Summary and Discussion of Studies 
 
Summary and Discussion of Studies 
	 	 	 26 
 
2.1. Study 1: Ventral striatal hypoactivation is associated with apathy 
but not diminished expression in schizophrenia1 
Previous studies have shown that patients with schizophrenia and their relatives show 
reduced activation in the ventral striatum during reward anticipation, although there are also 
reports where no significant differences were found, particularly in patients treated with 
atypical neuroleptics (Grimm et al., 2014; Juckel et al., 2006; Leeuw, Kahn, & Vink, 2015; 
Nielsen et al., 2012; Schlagenhauf et al., 2008; Simon et al., 2010). Additionally, some 
studies reported a correlation of (blunted) striatal activity with negative symptoms, or apathy 
(Simon et al., 2010; Waltz et al., 2010). However, no study has yet provided results that this 
association is specific to the factor apathy, and not related to the factor diminished 
expression. The aim of our study was to clarify the exact nature of this association. Our 
hypothesis was that the ventral striatal (hypo-)activation during reward anticipation was 
specifically related to apathy, and not to diminished expression.  
 
We recruited 27 patients with schizophrenia and 25 healthy controls who all performed a 
variant of the monetary incentive delay task (MID) during event-related fMRI. The MID task 
allows investigating various reward components, among others, reward anticipation. Each 
trial starts with the presentation of a cue that indicates a certain reward context, followed by a 
delay of 2 – 3 seconds (= reward anticipation phase). We included three different cues, 
indicating three different contexts: a neutral context, a low reward context and a high reward 
context. Subsequent to the presentation of the cue and the delay, participants have to react 
to a target stimulus. Out of three symbols in a row, they need to identify an outlier (which was 
either the symbol on the left or on the right side) and press the according response button. In 
case of a correct answer to the target stimulus, participants receive a reward for their 
performance. In contrary to the original version of the MID developed by B. Knutson, Fong, et 
al. (2001), reward outcome in our version was not determined probabilistically, but directly 
influenced by individual performance. The rationale behind a direct link of performance and 
outcome was that it better simulates goal-directed behavior, since outcome was completely 
determined by behavior. Additionally, this modification also enabled us to study adaptive 
coding of reward (see chapter 2.3). Furthermore, our MID task contained an algorithm that 
calculated the performance on basis of the last 15 response times of the previous 15 correct 
trials. This modulation should account for individual differences in response time and thus 
lead to constant rewards in all subjects. Importantly, all subjects performed 2 practice 
sessions before the actual experimental session started. The first practice session was 
performed outside the MRI scanner and was meant to familiarize the participants with the 																																																								
1 Please see appendix A for full-length research paper 
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task and served to measure the range of individual response times. For the second practice 
session inside the MRI scanner, the subject specific response times were used to calculate 
performance. During this practice session, subjects could get used to the new environment 
and the response box while the task has already adapted to the individual response times. 
 
Analyzing the behavioral data, we found a significant main effect of reward regarding 
response time. More specifically, we found that participants were significantly faster with 
increasing reward levels, a phenomenon called reward-related speeding. There was no 
group difference regarding response time and we found no correlation of reward-related 
speeding and negative symptoms. On the neural level, we found that patients and healthy 
controls activated the ventral striatum stonger when anticipating a reward compared to when 
anticipating no reward. We did not find a significant difference in ventral striatal activation 
between groups. This result is in line with results reported by Juckel et al., (2006), 
Schlagenhauf et al. (2008), and Simon et al. (2010), who also found no significant difference 
between patients treated with atypical neuroleptics and healthy controls. Our correlation 
analyses however showed that the activity in the VS was significantly and specifically 
correlated with apathy, but not with diminished expression. The two significantly different 
correlations provide evidence of a specific association of VS activation and apathy. To our 
knowledge, this is the first study showing this specific association, which provides strong 
support for the idea of different underlying neural correlates of apathy and diminished 
expression. Furthermore, these results provide a link for a pathophysiological mechanism of 
apathy. We argue that reduced activation in the VS reflects a reduction in wanting of 
potential rewards. If a person cannot be motivated to achieve a certain reward in the future, 
he will not engage in goal-directed behavior, which can – in extreme cases – lead to 
apathetic behavior as seen in patients with negative symptoms. The strong link between 
apathy and reduced VS activity might also explain the mixed findings of group differences in 
VS activation, meaning that it depends on the level of apathy in the patient group whether a 
group difference becomes significant or not. 
 
In sum, we present results showing that ventral striatal activity during reward anticipation is 
inversely correlated with apathy, but not with diminished expression. We are the first group to 
report a differentiation of the two negative symptoms factors on a neurobiological level. The 
implication of this intriguing finding is twofold: First, we argue that hypoactivation in the 
ventral striatum specifically reflects reduced wanting of a reward, which leads to a reduction 
of goal-directed behavior and the expression of apathetic behavior in patients with 
schizophrenia. Second, the specific correlation of ventral striatal activity during reward 
anticipation with apathy supports the notion that the two negative symptom factors have 
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specific underlying neurobiological mechanisms. This evidence of a differentiation of the two 
factors highlights the importance of assessing both factors carefully and targeting treatment 
for both factors separately.  
 
 
2.2. Study 2: Reward-Dependent Modulation of Working Memory is 
associated with Negative Symptoms in Schizophrenia2  
Research on dysfunctions in reward processing and cognition has long been conducted 
separately (Braver et al., 2014; Pessoa, 2009). Likewise, deficits in these domains have 
been related to separate, functionally specialized brain regions (Pessoa, 2008). While reward 
processing has been linked to mainly dopaminergic midbrain regions, such as the ventral 
striatum, cognitive processing deficits have been associated with aberrant activity in primarily 
prefrontal regions (Barch & Ceaser, 2012; Juckel et al., 2006; Manoach, 2003; Nielsen et al., 
2012; Schlagenhauf et al., 2008; Simon et al., 2010; Waltz et al., 2010). However, recent 
work suggests a strong interaction between cognition and reward. In line with this notion, 
various studies have shown that the prospect of a reward promotes performance in multiple 
task domains and leads to the modulation of cognitive brain regions (Chiew & Braver, 2011; 
Krebs et al., 2012; Locke & Braver, 2008). It is thought that the outlook of a reward prioritizes 
processes that lead to the harvest of the potential reward by the assignment of additional 
resources or by withdrawing resources from other concurrent processes. The ACC has been 
suggested to play a pivotal role in this process by acting as a hub, thereby linking cognitive 
and affective brain regions. It is theorized that the ACC is engaged by reward-related regions 
such as the VS and OFC and further influences prefrontal regions associated with cognition 
and cognitive control (Pessoa, 2009; Vassena et al., 2014).  
 
The aim of this explorative study was to elucidate whether negative symptoms reflect 
problems in using reward information to increase cognitive performance. Our hypothesis was 
that patients with schizophrenia would not profit as much from a reward enhancement effect 
as healthy controls. Furthermore, we expected that impairments in reward modulation are 
correlated with negative symptom severity. On the neural level, we hypothesized that 
enhanced activity in the ACC and other working memory related regions induced by the 
reward-cognition interaction was significantly lower in the patient group compared to the 
healthy control group. Additionally, our hypothesis was that this attenuated effect correlated 
with negative symptoms. 
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Summary and Discussion of Studies 
	 	 	 29 
 
To operationalize an interaction of reward and cognition, we applied a letter variant of the n-
back working memory task and varied the incentive for performance. We manipulated 
cognitive load (0-back vs. 2-back) and the amount of reward (no reward/reward) for 
performance, which resulted in a total of 4 different conditions. In the 0-back condition, 
participants were required to press a button whenever the letter “x” appeared on the screen. 
In the 2-back condition, participants had to press a button, whenever the letter they saw was 
equal to the letter presented before the last one. Each trial consisted of twelve letters and 
contained 4 target stimuli (hits). At the beginning of a trial, participants were informed about 
the cognitive load (0-back/2-back) and the level of reward (reward/no reward) of the 
upcoming trial. At the end of each trial, after participants performed the working memory 
task, they received feedback about their performance, which was measured as the 
standardized probability of a hit minus the standardized probability of a false alarm, also 
called sensitivity index d’. Additionally, we measured response time, i.e., the time to respond 
after the presentation of a hit. The amount of reward they won – in case of a rewarded trial – 
depended directly on their performance, i.e., on the sensitivity index d’. 
 
With regard to performance (= sensitivity index d’), we did not find a significant difference 
between both groups. However, across all subjects, we found a significant main effect of 
cognition, meaning that participants performed significantly better in the 0-back condition 
relative to the 2-back condition. We did not find any significant effect of reward or any 
significant interaction effect on accuracy. Likewise, we did not find any significant correlation 
of negative symptoms and sensitivity. Regarding response time, we found a main effect of 
group, indicating that the healthy control group responded significantly faster than the patient 
group across conditions. Across groups, we also found a main effect of cognition, showing 
that participants were faster in the condition with low cognitive load, and a main effect of 
reward, implicating that participants responded faster in case of a rewarded trial. However, 
we did not find any interaction effect. Regarding associations of response time and negative 
symptoms, we found a significant correlation of apathy with the factor cognitive load and the 
reward-cognition interaction ((2-back/reward – 0-back/reward) – (2-back/no reward – 
0back/no reward)), indicating that cognitive load and the integration of complex information 
reduces response time in patients with apathy. 
 
Regarding the imaging data, we focused our analyses on the reward-cognition interaction 
contrast ((2-back/reward – 0-back/reward) – (2-back/no reward – 0back/no reward)) and 
restricted our search volume, based on our a priori hypothesis, to the frontal cortex (including 
ACC). Pooling over all subjects, we found significant activation in the bilateral and medial 
superior frontal gyrus and the right rostral anterior cingulate. This finding is in line with our a 
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priori hypothesis: Because the successful completion of the working memory task led to a 
financial reward, the respective process was prioritized and additional cognitive resources 
were recruited in order to maximize performance. The proposed mechanism is that the ACC 
exerts its influences to control resource demands via interconnections with cortical areas, 
such as the (pre-)motor cortex and the lateral prefrontal cortex, which might explain the 
significant activation in these regions. In sum, we found 4 clusters that were significantly 
more active when working memory performance (2-back vs. 0-back) was rewarded, 
compared to when it was not rewarded, suggesting a role of these regions in integrating 
reward information and cognition. When comparing the groups, we did not find any 
significant differences between the healthy control group and the patient group, implying an 
intact neural mechanism in schizophrenia. However, within the patient group, we found that 
activity in the ACC was significantly and specifically correlated with the factor diminished 
expression, indicating that patients with more severe diminished expression symptoms have 
difficulties in (up-)regulating their processing resources in order to meet the current resource 
demand. This finding is in line with the cognitive resource limitations model of diminished 
expression proposed by Cohen et al. (2014; 2012). This model is based on the fact that 
expressive behavior requires a range of mental resources. During a social interaction for 
example, individuals must track and update the conversation, integrate and hold important 
information, observe the implicit and explicit behavior of the conversational partner, and so 
forth. The cognitive resource limitations model suggests that diminished expression result 
from a lack of available resources. Our data extends this theory by suggesting that patients 
with more diminished expression do not solely have less cognitive resources, but experience 
difficulties in adjusting their resources according to priority, which results in diminished 
expressivity.  
 
To summarize, in study 2, we investigated the effects of prospective rewards on working 
memory performance in patients with schizophrenia and healthy controls. We found that 
anticipating a reward in a cognitively effortful task leads to an additional activation of the 
rostral anterior cingulate (ACC) and the lateral prefrontal cortex in both groups. This finding is 
in line with previous research demonstrating that rewards lead to enhanced brain activity in 
task-related regions, regions involved in executive control, and so-called hub regions, like the 
ACC. We did not find any significant group difference in the reward-cognition interaction on 
the behavioral and neural level. This indicates that patients with schizophrenia are able to 
integrate information about prospective rewards and utilize this information in order to 
increase their performance. However, within the patient group, we found that the enhanced 
ACC activity in the rewarded vs. non-reward working memory contrast was inversely 
correlated with the negative symptom factor diminished expression. This finding is generally 
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in line with the cognitive resource limitation model proposed by Cohen (2012), which 
proposes that – based on the fact that expressive behavior requires a range of mental 
resources – diminished expression originates from a lack of available cognitive resources. 
We expand this model by arguing that patients with diminished expression not only have less 
cognitive resources available, but that they are not able to recruit sufficient cognitive 
resources to meet the required demands of rewarded tasks and hence, show diminished 
expression. Furthermore, we are the first group to propose a potential neurobiological 
mechanism of diminished expression. 
 
 
2.3. Study 3: Deficits in Context-dependent Adaptive Coding of Reward 
in Schizophrenia3 
Schizophrenia has been associated with various reward processing abnormalities. It is 
thought that these deficient processes are – besides or instead of primary cognitive 
impairments – jointly responsible for several critical cognitive and affective deficits. While 
negative symptoms have been linked to reward anticipation deficits (see chapter 2.1 & 2.2), 
impaired reinforcement learning (RL) and aberrant cost-benefit computations, positive 
symptoms have been implicated with the aberrant coding of salience (for review see Barch et 
al., 2015; Gold et al., 2008; Strauss et al., 2013). A commonality of all these deficient 
processes is the requirement of a precise representation of reward. In order to precisely 
encode a potentially infinite quantity of rewards with only a limited number of reward coding 
neurons, neurons adjust their coding range to the current (reward) context (Tobler et al., 
2005). With this efficient allocation of resources, neurons can exploit their entire dynamic 
range within any given context, thereby guaranteeing optimal sensitivity and discriminability 
between different rewards. The aim of our study was to elucidate whether potential deficits in 
context-dependent adaptive coding could reflect a basic dysfunction of reward processing in 
schizophrenia and whether there is a correlation of the degree of adaptive coding with 
symptomatology. 
 
To elucidate the adaptation of neural sensitivity to the currently available rewards, we 
analyzed the data of the MID task of the sample described in chapter 2.1. However, in 
contrary to study 1, we focused our analyses on the reward outcome phase and not on the 
reward anticipation phase, which reflects reward representation as compared to reward 
anticipation. As outlined in chapter 2.1, a cue at the beginning of each trial determines the 
current reward context. Our version of the task consisted of three different cues, indicating 																																																								
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three different reward contexts: a no reward context, a low reward context, and a high reward 
context. In the low reward context, participants could win between CHF 0 and CHF 0.4, in the 
high reward context, they could win between CHF 0 and CHF 2. Due to the different reward 
range in the low and high reward context, it is possible to investigate adaptation of neural 
sensitivity to rewards. According to the efficient coding hypothesis, the slope of the neural 
response function should be steeper with a smaller reward range compared to a larger 
reward range because neurons always adapt to the currently available rewards to exploit 
their entire dynamic firing range. Hence, in order to test for adaptive coding, we tested the 
slope difference of the neural response functions of both reward contexts and compared both 
groups for significant differences. Furthermore, we tested whether there is an association of 
the degree of adaptive coding with psychopathological ratings.  
 
Regarding response time, we found a significant main effect of reward, showing that 
participants responded faster in the high reward context compared to the low reward context 
(see also chapter 2.1). This finding indicates that participants adapted their behavior to the 
current context. Within the patient group, we did not find any significant correlation of 
reaction time and symptom severity. On the neural level, we found two reward coding 
regions in our patient group that did not show adaptive coding compared to healthy controls: 
the right caudate and the right anterior insula/inferior frontal gyrus. More specifically, our 
analysis implies that within these two regions, healthy controls – in comparison to patients 
with schizophrenia – show a significantly steeper slope of the neural response function in the 
low reward context compared to the high reward context. This finding provides strong 
evidence for efficient neural adaptation in healthy controls, but not in the patient group. By 
further analyzing the neural response functions of the patient group, we found that 
particularly in the low reward context, the slopes of neural response functions were very flat, 
only exploiting a fraction of the potential response range. Flat response functions make 
discriminability between different reward amounts extremely challenging and hence, lead to 
imprecise representations of reward information. Since an accurate representation of reward 
is a prerequisite for any functional reward-related process, imprecisions in the representation 
could contribute to a wide range of deficient reward processes in schizophrenia. Regarding 
reinforcement learning deficits, Strauss et al. (2011) and Gold et al. (2012) report findings 
that are in line with this theory by suggesting that reinforcement learning deficits are caused 
by difficulties in representing the relative value of response alternatives. In a study published 
in 2013, Gold et al. further argue that this deficit could contribute to abnormalities in effort-
based decision making. They argue that it is difficult to perform accurate cost-benefit 
computations if the benefits are not represented precisely. The imprecise representation of 
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reward information could also be involved in the aberrant assignment of salience, which is 
proposed as a mechanism for delusions (Kapur, 2003).  
 
Furthermore, we found that the degree of the adaptive coding deficit is related to the general 
symptomatology of patients with schizophrenia, suggesting that this is a basic dysfunction 
instead of a specific neural correlate of positive, negative or depressive symptoms. This 
theory is supported by the fact that adaptive coding deficits could be responsible for aberrant 
reward-related processes associated with positive and negative symptoms. Another aspect 
that supports the notion of a general deficit is that context-dependent adaptation is ubiquitous 
and not only found in reward coding, but as well in sensory processing, which is also 
deficient in schizophrenia. Additionally, various studies suggested that the core deficit in 
schizophrenia is an accurate processing of contextual information, which is in line with the 
theory of a general information processing deficit (Hemsley, 2005). 
 
In sum, we are introducing a new concept in schizophrenia research: the contextual 
adaptation of neural sensitivity to the current reward context. We show for the first time that 
patients with schizophrenia have deficits in adaptive coding of reward. A deficit in the 
adaptation to the current reward context leads to a diminished discriminability of rewards and 
causes an imprecise representation of reward information. Such an imprecise representation 
might have far-reaching consequences and could lie at the root of many dysfunctional reward 
processes in schizophrenia. We believe that this deficient mechanism of context-dependent 
adaptation might help to explain some of the known deficits in reward-related processes in 
schizophrenia, such as deficits in reinforcement learning, cost-benefit decision making, and 
salience coding. Furthermore, we provide evidence that the degree of the adaptive coding 
deficit is related to the general symptom severity of patients with schizophrenia. The 
association with the general symptomatology, in combination with the ubiquity of this process 
in the brain, suggests that this deficit could reflect a more basic dysfunction in schizophrenia. 
This is also in line with early studies suggesting that the core deficit in schizophrenia is the 
processing of contextual information. 
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3. General Discussion 
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3.1. Reward processing as a unifying framework for studying 
schizophrenia 
Although motivational impairments and learning deficits have long been recognized as 
crucial impairments in schizophrenia, it has only been recently that researchers and 
clinicians studied these symptoms within a reward processing framework. A driving force that 
contributed to the effort in understanding certain aspects of the symptomatology of 
schizophrenia as reward-related dysfunctions were the significant advancements in 
understanding how organism process rewards. Central to this progress was the insight that 
reward processing is not a unitary construct, but consistent of several components (see 
chapter 1.1). The proposition of sophisticated behavioral theories of reward facilitated the 
development of behavioral paradigms, which subsequently promoted a better understanding 
of the functional neuroanatomy and neurochemistry of the various reward-related processes. 
Research revealed evidence that different reward components rely on partially differentiable 
brain circuits. This discovery highlighted the critical role of dopamine in motivation and 
learning. Another driving force behind the effort of studying schizophrenia in the light of 
reward processing deficits was a better understanding of the symptomatology, in particular 
the idea of a dimensional model of schizophrenia. In sum, the clear role of dopamine in 
reward processing and the pathology of schizophrenia, in combination with the marked 
motivational and learning deficits in patients with schizophrenia, made the reward system an 
interesting framework for studying positive, negative, and cognitive symptoms (Barch, 
Pagliaccio, & Luking, 2015; Wolfram Schultz, 2015; Ziauddeen & Murray, 2010) 
 
The results of this dissertation provide further evidence that reward processing serves as an 
excellent framework to understand certain aspects of the symptoms of schizophrenia. By 
elucidating different psychological components of reward, we found evidence for relations to 
specific as well as general symptoms. In study 1, we found that ventral striatal activity during 
reward anticipation is specifically related to the factor apathy. We argue that a hypoactivation 
of the ventral striatum during reward anticipation reflects disrupted wanting, which causes a 
reduction in approach behavior. In more pronounced forms, this reduction can be expressed 
as apathy. In study 2, we elucidated another aspect of wanting: we applied a behavioral 
paradigm that allowed studying whether the anticipation of reward leads to a modulation of 
cognitive performance. On the neural level, the ACC has been suggested to play a pivotal 
role in this modulation, providing a link between cognition and reward. Our results suggest 
that patients with schizophrenia are – in general – able to recruit additional cognitive 
resources when confronted with the prospect of a reward. However, we found that ACC 
activity is inversely related to the factor diminished expression, which implicates that 
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diminished expressivity is caused by an inability to manipulate perceptual resources in order 
to meet the current demand. This finding is generally in line with the theory that diminished 
expressivity is caused by a lack of cognitive resources. However, we expand this theory by 
proposing that it is not only the lack of cognitive resources, but also the ability to modulate 
these resources, which contributes to diminished expression in schizophrenia. Additionally, 
we provide first evidence for an underlying neural mechanism of diminished expression. In 
study 3, we investigated deficits in reward learning, more specifically, deficits in reward 
representations. We could show that patients with schizophrenia do not adapt neural 
sensitivity to the current reward context, which leads to imprecise reward representations. 
This deficit could contribute to abnormalities in various reward processes in schizophrenia, 
since merely all reward processes require an accurate representation. Additionally, we found 
that this deficit is related to the general symptomatology. With regard to the ubiquity of this 
process, we believe that these findings provide an avenue to defining a general impairment 
in information processing that underlies this disorder. 
 
In sum, we could show that abnormalities in phasic and tonic forms or reward anticipation 
and deficits in adaptive coding of reward can contribute to a better understanding of the 
symptoms and the underlying neurobiology of patients with schizophrenia. This supports the 
endeavor to study the pathophysiological mechanism of positive, negative, and cognitive 
symptoms in the light of reward processing deficits and highlights the crucial role of 
dopaminergic abnormalities in schizophrenia. 
 
 
3.2. Clinical implications 
Experimental paradigms that are based on sophisticated behavioral theories of reward 
processing provide an excellent approach to study the neural underpinnings of symptom 
dimensions in schizophrenia. In this dissertation, we present evidence that relates negative 
and positive symptoms to deficits in specific reward-related processes with distinct 
neurobiological correlates. Neural activity in these regions could therefore serve as 
neuroimaging markers for pharmacological or psychotherapeutic treatment trials. 
Furthermore, reward processing tasks could complement the psychopathological 
assessments conducted by the clinician, since patients’ self-reports have shown to be biased 
(Strauss & Gold, 2012).   
 
The proposed mechanisms for apathy (study 1) and diminished expression (study 2) could 
be helpful for the development of psychotherapeutic interventions. Study 1 suggests that 
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apathy is related to a reduced anticipation of rewards. It would be interesting to see whether 
reward anticipation can be enhanced by applying emotion regulation strategies. If so, these 
strategies could be implemented in everyday life in order to promote goal-directed behavior. 
Study 2 provides evidence that diminished expression is not only based on limited 
processing capacities, but additionally, on the appropriate regulation of these processing 
capacities. In addition to cognitive training, patients could be taught how to optimally prioritize 
tasks in order to ensure sufficient capacities, thereby reducing their diminished expressivity.  
 
Finally, with respect to the innovation of psychopharmacological interventions, our findings of 
deficient adaptive coding (study 3) may contribute to basic research regarding the 
development of novel therapeutics ameliorating these deficits.  
 
 
3.3. Limitations  
Certain limitations concern all three studies presented in this dissertation. Although we did 
not find any statistical effect of antipsychotic medication, we cannot fully exclude potential 
confounding effects on the symptomatology, and the dopaminergic system in general. It 
would therefore be critical to replicate these studies with antipsychotic naïve patients and 
patients with first generation antipsychotics. Also, patients in our sample had a relatively low 
variance in positive and depressive symptoms. This limits the ability to differentiate specific 
effects of these two symptoms dimensions. Furthermore, it would be important to not only 
include patients with a manifest disorder, but also patients with an increased risk in order to 
better understand the development of symptoms. Another limitation is that we only used one 
specific secondary reinforces to study reward processing. However, it would be crucial to 
include primary rewards, such as food, liquid, or erotic stimuli in order to generalize the 
observed deficits to all reward categories. The application of primary rewards would also 
facilitate the comparison with experiments based on animal models of schizophrenia and 
promote reward processing as a translational framework.  
 
 
3.4. Conclusion 
In this dissertation, we present findings that link positive and negative symptoms to 
alterations in normal motivational processing and reward learning. We could show that 
deficits in certain subcomponents of reward processing map onto partially separable 
neurobiological substrates in schizophrenia, which paves the way for the development of 
new psychological and pharmacological treatment and intervention strategies.  
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Furthermore, we could show that reward processing is an optimal framework for studying 
motivational impairments and deficient learning processes in schizophrenia. Since these 
deficits are also core aspects of other psychopathologies, such as major depression and 
bipolar disorders, a reward processing framework can be used to study impairments across 
diagnostic boundaries. This will allow elucidating whether there are common psychological or 
neurobiological mechanisms underlying reward processing abnormalities across 
psychopathologies, or whether there are very specific, separable mechanisms contributing to 
each mental disorder. 
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Abstract: 
 
Background: Negative symptoms of schizophrenia can be grouped in two dimensions - 
apathy and diminished expression. Increasing evidence suggests that negative symptoms 
are associated with altered neural activity of subcortical and cortical regions in the brain 
reward system. However, the neurobiological basis of the distinct symptom dimensions 
within negative symptoms is still poorly understood. The primary aim of the study was to 
examine the neural correlates of the negative symptom dimensions apathy and diminished 
expression during a reward processing task.  
 
Methods: 27 patients with schizophrenia and 25 healthy controls underwent event-related 
fMRI while performing a variant of the monetary incentive delay task. Negative symptom 
dimensions were assessed with the Brief Negative Symptom Scale. 
 
Results: Both groups showed neural activation indicated by BOLD signal in the ventral 
striatum during reward anticipation. Ventral striatal activation during reward anticipation 
showed a strong negative correlation with apathy. Importantly, this effect was not driven by 
cognitive ability, medication, depressive or positive symptoms. In contrast, no significant 
correlation with the diminished expression dimension was observed.  
 
Limitations: Although the results remain significant when controlling for chlorpromazine 
equivalents, we cannot fully exclude potential confounding effects of medication with atypical 
antipsychotics.  
 
Conclusions: The specific correlation of ventral striatal hypoactivation during reward 
anticipation with apathy demonstrates a differentiation of apathy and diminished expression 
on a neurobiological level and provides strong evidence for different pathophysiological 
mechanisms underlying these two negative symptom dimensions. Our findings contribute to 
a multilevel framework, in which apathy and motivational impairment in schizophrenia can be 
described on psychopathological, behavioral and neural levels. 
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1. Introduction 
Negative symptoms are core symptoms of schizophrenia (SZ) and include avolition, 
anhedonia, asocialty, blunted affect and alogia 1,2. They contribute strongly to poor functional 
outcome and reduced subjective quality of life 3–5. Despite these consequences, current 
knowledge about the underlying pathophysiology remains limited, hindering the development 
of effective treatment strategies.  
 
There is now a consensus that negative symptoms can be grouped into two dimensions 2,5,6. 
First, a motivational dimension, which we refer to as apathy, combines anhedonia, avolition, 
and asociality. Second, a diminished expression dimension includes blunted affect and 
alogia. Importantly, it has been suggested that different neurobiological mechanisms may 
underlie these dimensions, which would be highly relevant for identifying specific treatment 
strategies 1,7,8. 
 
Apathy can be defined as reduction of motivation and goal-directed behavior 9,10. Several 
behavioral studies have shown that motivational impairments in schizophrenia are 
associated with dysfunctional processing of reward information in effort-based decision 
making 11,12, reinforcement learning and during reward anticipation 13,14. On the neural level, 
the ventral striatum (VS) appears to play an important role in coding of incentive motivation 
15,16 or “wanting” of a reward 17. There is now consistent evidence for  striatal dysfunction 
during reward anticipation in individuals with schizophrenia and their relatives 18–22. 
Importantly, several research groups have found an association between negative symptom 
severity and reduced activation in the VS, although there are some divergent findings 23–30. 
Additionally a relationship between negative symptoms and reduced activity in the dorsal 
striatum during reward processing and cognitive processing tasks were observed 31,32. Two 
studies including our own suggest that ventral striatal hypoactivation might be more strongly 
related to apathy than global negative symptoms 28,29. Data from a positron emission 
tomography study showing an inverse correlation between dopamine levels within the VS 
and apathy support this idea 33. However, in prior studies a clear distinction between 
neurobiological correlates of apathy and diminished expression was not demonstrated. This 
might be due to several reasons: Previous research mainly focused on total negative 
symptom scores or concentrated on neurobiological correlates of apathy alone. Finally, 
relatively small samples likely made it difficult to disentangle between apathy and diminished 
expression. 34.  
 
The primary aim of the present study was to investigate the specific association between 
apathy and diminished expression and neural correlates of reward processing in individuals 
with schizophrenia. We used the new Brief Negative Symptom Scale (BNSS) 35 to assess 
these two psychopathological dimensions. To investigate the neural activity during 
anticipation of reward we employed a variant of the Monetary Incentive Delay Task 15. We 
hypothesized that apathy but not diminished expression is  associated with hypofunction in 
the VS during reward anticipation. In addition, since a role for the orbitofrontal cortex (OFC) 
in the pathophysiology of negative symptoms has been suggested 14, we investigated the 
association between OFC activation during reward outcome processing and the negative 
symptom dimensions in an exploratory analysis. 
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2. Methods and Materials 
2.1. Participants 
Initially, 30 patients with schizophrenia (SZ) and 28 healthy control participants (HC) were 
included. 5 participants (2 SZ, 3 HC) were excluded because of head movement and one 
participant with schizophrenia was excluded due to signal dropout in functional images, 
resulting in a sample of 27 patients and 25 healthy controls. Participants with schizophrenia 
were recruited from outpatient (n = 11) and inpatient (n = 16) units of the Psychiatric Hospital 
of the University of Zurich or from institutions affiliated with the Psychiatric Hospital. All 
patients with schizophrenia were clinically stable and received a stable dose of medication 
(for further details, see Supplementary Methods 1.1.). The project was approved by the local 
ethics committee of the canton of Zurich. All participants gave written informed consent to 
participate in the study. The capability to give informed consent of each participant with 
schizophrenia was evaluated by the treating psychiatrist. 
 
Diagnosis of schizophrenia was confirmed in a structured Mini-International Neuropsychiatric 
Interview for DSM-IV 36. We excluded participants with any other DSM-IV axis I disorder (in 
particular current substance use disorder and major depressive disorder), medication with 
lorazepam higher than 1mg, florid psychotic symptoms, i.e. any positive subscale item score 
higher than four as measured with the Positive and Negative Syndrome Scale (PANSS) 37, 
and extrapyramidal side effects, i.e. a total score higher than two on the Modified Simpson-
Angus Scale (MSAS) 38. Healthy controls were screened for any neuropsychiatric disorders 
using the structured Mini-International Neuropsychiatric Interview 36 to ensure that they had 
no previous or present psychiatric illness. Both study groups - patients and healthy controls - 
were required to have a normal physical and neurological status and no history of major 
head injury or neurological disorder. 
 
2.2. Clinical and Neuropsychological Assessment 
In order to assess negative symptom dimensions, the BNSS 35 was administered to 
participants with schizophrenia. The apathy (motivation and pleasure) dimension score 
included avolition, asociality and anhedonia, while the diminished expression dimension 
score included alogia and blunted affect (for further details, see Supplementary Methods 
1.2). Further psychopathological assessment included the Scale for the Assessment of 
Negative Symptoms (SANS) 39, the PANSS, the Calgary Depression Scale for Schizophrenia 
(CDSS) 40, the Global Assessment of Functioning scale (GAF) 41, and the Personal and 
Social Performance Scale (PSP) 42. Moreover, both groups performed a neuropsychological 
test battery assessing different cognitive domains (for further details, see Supplementary 
Methods 1.2).  
 
2.3. Experimental Design and Task 
We used a variant of the Monetary Incentive Delay Task (MID) 15 with stimuli based on the 
Cued-Reinforcement Reaction Time Task 43. This variant allowed us to investigate reward 
anticipation and reward outcome, which was directly dependent on the individual task 
performance (Figure 1). Before starting the experiment all participants were informed that 
they would receive the complete amount of money won during the two experimental 
sessions. At the beginning of each trial, one of three different cues was presented for 0.75 s. 
The cue indicated the maximum possible amount participants could gain in that trial, i.e. 2 
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Swiss Francs (CHF), 0.40 CHF, or 0 CHF (1 CHF = 1.08 US $). After a delay, varying from 
2.5 to 3 s, the participants had to identify an outlier from three presented circles and press a 
button (either left or right) as fast as possible (varying from 0.32 to 1 s). Immediately, 
participants were notified of the amount of money they had won (duration of feedback 2 s). 
Error trials were defined as trials with a wrong response or late response (after 1s). In all 
other trials we calculated the actual amount of money to be won for each trial on the basis of 
the response times of the previous 15 individual trials (Figure S1 in Supplemental 
Information). This approach was used in order to account for individual differences in 
response time and thus ensure constant and high rewards in both groups. The maximum 
amount of money to be won was 50 CHF. Every participant performed two training runs, one 
outside and one inside the scanner. Excluding the training sessions, the experiment 
contained two runs with 36 trials of about 10 s each. The inter trial interval (ITI) was jittered 
from 1 to 9 s with a mean of 3.5 s to enhance statistical power. In total, one run lasted about 
6 min. The task was implemented using the MATLAB toolboxes Cogent 2000 and Cogent 
Graphics.  
 
2.4. Functional Image Acquisition 
Imaging data was collected with a Philips Achieva 3.0T magnetic resonance (MR) scanner 
using a 32 channel SENSE head coil (Philips, Best, The Netherlands) at the MR Zentrum of 
the Psychiatric Hospital, University of Zurich. Functional MRI (fMRI) was acquired in two runs 
with 195 images in each run. We used a gradient-echo T2*-weighted echo-planar image 
(EPI) sequence with 38 slices acquired in ascending order. Acquired in-plane resolution was 
3 × 3mm2, 3mm slice thickness and 0.5 mm gap width over a field of view of 240 × 240 mm, 
a repetition/echo time (TR/TE) of 2000/25ms and a flip angle of 82°. The first five scans were 
discarded to eliminate the influence of T1 saturation effects. Slices were aligned with the 
anterior–posterior commissure. Anatomical data was acquired with an ultrafast gradient echo 
T1-weighted sequence in 160 sagittal plane slices of 240 × 240 mm resulting in 1 x 1 x 1 mm 
voxels. 
 
2.5. Data Analyses 
All demographic, clinical, neuropsychological and behavioral data, as well as the correlations 
were analyzed using IBM SPSS Statistics Version 22. Normal distribution was tested with the 
Kolmogorov-Smirnov Test. We analyzed fMRI data using SPM8 (Statistical Parametric 
Mapping, Wellcome Department of Cognitive Neurology, London, UK). 
 
2.5.1. Behavioral Data Analyses 
The main behavioral outcome measure was response time, defined as time between target 
presentation and pressing the correct answer button. We performed a two-way repeated 
measures analysis of variance (ANOVA) with group as between-subject factor and reward 
condition (neutral, low, high) as within-subject factor. We performed Mauchly’s test for the 
assumption of sphericity. In case of violations of the assumption of sphericity we reported 
Greenhouse Geyser corrected degrees of freedom. As post-hoc tests for significant main 
effects, we applied Bonferroni corrected pairwise comparisons. 
 
Furthermore, we performed correlation analysis between negative symptom factors and 
reward-related speeding. Reward-related speeding was calculated by subtracting the 
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response time during the neutral condition (CHF 0) from the response time during the high 
reward condition (CHF 2.0) divided by the mean of these two conditions.  
 
Potential group differences in all other behavioral data were investigated using two sample t-
tests. For non-normally distributed data Mann-Whitney U tests were applied. 
 
2.5.2. Image Preprocessing 
Functional images were corrected for differences in the time of slice acquisition and motion 
using the realign and unwarp function of SPM8. A voxel displacement map, calculated from 
double phase and magnitude field map data, was used to correct for combined static and 
dynamic distortions. We performed segmentation, bias correction, and spatial normalization. 
Finally, images were smoothed using a Gaussian kernel of 6 mm width at half maximum. To 
assure adequate quality of fMRI Data subjects with translational head movement > 3mm or 
extensive signal dropout in the EPI sequences were excluded. Following previous studies 
from van Dijk and Satterthwaite et al. range of motion were calculated as mean relative 
displacement (MRD) and used for subsequent analyses 44,45. Mean MRD did not differ 
significantly between healthy controls (mean MRD = .11, SD = .03) and patients with 
schizophrenia (mean MRD = .11, SD = .04) (p = .43). 
 
2.5.3. First and Second Level Image Analyses 
We used a general linear model (GLM) approach to assess our data in an event-related 
design at the first level. For the three different reward anticipation phases separate 
regressors were included: anticipation of no reward (CHF 0), anticipation of low reward (CHF 
0.40) and anticipation of high reward (CHF 2.0). For the outcome phases we included one 
regressor for each condition (three basic regressors). Additionally, for the low (CHF 0.40) 
and high reward condition (CHF 2.0) the two outcome regressors were parametrically 
modulated by the actual outcome amount of each trial. Target presentation (one regressor) 
and anticipation, target and outcome phase in error trials (three regressors) were modelled 
as regressors of no interest. In total, the first level model included twelve regressors. The 
canonical hemodynamic response function was used for convolving all explanatory variables. 
For reward anticipation we calculated the contrast anticipation of high reward (CHF 2.0) 
versus anticipation of no reward (CHF 0). For the analysis of the outcome processing phase, 
we used the parametric modulator for high reward (CHF 2.0). At the second level of analysis, 
we included the individual contrast images of all participants in a random-effects model. We 
calculated within-group activation using a one sample t-test and between-group activation 
using a two sample t-test.  
 
2.5.4. Region of Interest Image Analysis 
In line with our a priori hypothesis, we defined the VS as region of interest (ROI) during 
anticipation of reward. Coordinates for the VS were derived from a meta-analysis of Knutson 
et al. (left: x = -12, y = 10, z = -2; right: x = 0, y= 8, z = 0) investigating previous fMRI studies 
using the MID task 46. This approach was adopted from a recent study of Yip et al. who 
investigated ventral striatal activity in patients with bipolar disorder 47. . In addition to the VS, 
we defined the medial orbitofrontal cortex (mOFC) as region of interest for analysis of 
activation during the outcome phase. The mOFC ROI was constructed as an anatomical 
voxel mask with the Individual Brain Atlases using Statistical Parametric Mapping (IBASPM 
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71) 48 implemented in the WFU Toolbox 49. The statistical thresholds were set at a p = .05 
voxel-level family-wise error (FWE) rate correction of p = .05 for multiple comparison in each 
ROI. Mean percent signal changes were extracted for all voxels in the VS and mOFC ROI 
using the REX toolbox (http://web.mit.edu/swg/software.htm). 
 
2.5.5. Correlation Analysis 
We tested our main hypothesis by calculating bivariate Pearson correlations (r) between 
negative symptoms (apathy and diminished expression) and percent signal change in the VS 
and mOFC. Partial correlations were calculated to control for potential confounding variables. 
Finally, we performed the Steiger test for dependent correlation coefficients to test for 
potential differences between these correlations 50.  
 
 
3. Results 
3.1. Sample Characteristics 
Participant demographics, clinical data and group comparisons are summarized in Table 1. 
In line with previous research, the two negative symptom dimensions apathy and diminished 
expression correlated significantly (r = .45, p < .02) 12. 
 
3.2. Behavioral Data 
Regarding response time the repeated measures ANOVA revealed no significant main effect 
of group [F (1, 50) = 2.6, p = .12], but a significant main effect of reward [F (1.4, 69) = 34.0, p 
< .001]. Post hoc pairwise comparison of the response time showed significant differences 
between all three conditions (all ps = <.001). Participants were significantly faster in low vs 
no, high vs low and high vs no reward condition (Figure S2 in Supplemental Information). 
These results indicate intact reward-related speeding in both groups. There was no 
significant group X reward interaction effect [F (1.4, 69) = .65, p = .47]. Furthermore, reward-
related speeding did not correlate significantly with apathy (r = -.22, p = .26) or diminished 
expression (r = .02, p = .9). Additionally, to control for differences in cognition, we performed 
an analysis of covariance with the composite cognitive ability score as covariate, which did 
not change the significance levels in the repeated measures ANOVA.  
 
Because of low error rates in all three conditions we used total error rates for group 
comparison. We did not find any differences between healthy controls and patients with 
schizophrenia (U = 313.5, p = .66, see Table 2). Finally, differences in total gain were 
significant (t = 2.1, p= .04), but small (Table 2). 
 
3.3. Functional Imaging Data  
3.3.1. Anticipation of Reward: VS 
We focused on brain activation during anticipation of high reward versus no reward. Our a 
priori defined region of interest was the VS. Healthy controls (left VS: cluster size = 428, t = 
5.72; right VS: cluster size = 398, t = 5.60, both p < .05, FWE corrected) and patients with 
schizophrenia (left VS: cluster size = 259, t =5.44; right VS: cluster size = 361, t = 5.42, both 
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p < .05 FWE corrected) showed significantly stronger activation in the VS during anticipation 
of high reward as compared to anticipation of no reward (Figure 2). However, in the group 
comparison we did not find any significant differences during anticipation of high reward 
versus no reward either in the left or in the right VS. Importantly, all significance level 
remained unchanged when including the composite cognitive ability score as covariate. 
 
3.3.2. Correlation between Anticipation of Reward and Negative Symptoms 
Regarding our primary hypothesis we found a highly significant negative correlation between 
percent signal change in VS during reward anticipation and apathy in the left VS (r = -.47, p = 
.01) (Figure 3) and in the right VS (r = -.38, p = .05). Thus, a higher apathy score was 
associated with less ventral striatal activation during anticipation of high reward in relation to 
anticipation of no reward. In contrast, no significant correlation between diminished 
expression and percent signal change in the VS during reward anticipation was observed in 
the left VS (r = -.001, p = .997) (Figure 3) and right VS (r = .09, p = .65). These correlation 
coefficients were significantly different from each other (left VS: tDiff = 2.40, p = .02; right VS: 
tDiff = 2.32, p = .02), i.e. apathy was more strongly associated with reduced ventral striatal 
activation than diminished expression. Additionally, we performed whole brain voxelwise 
exploratory correlation analyses revealing no additional cluster showing significant 
correlation of apathy or diminished expression with activation during reward anticipation. 
 
None of the potential confounding variables such as chlorpromazine equivalents (left VS: r = 
-.05, p = .82; right VS: r = .01 p = .95), depressive symptoms (CDSS) (left VS: r = .45, p = 
.02; right VS: r =.34, p =.08), positive symptoms (PANSS positive factor) (left VS: r = -.23, p = 
.26; right VS: r = -.17, p = .4), cognition (composite cognitive ability score) (left VS: r = .05, p 
= .8, right VS: r = .12, p = .5) and total amount of gain (left VS r = .22, p = .27; right VS: r = 
.28, p = .16) were significantly associated with reduced ventral striatal activation. 
Furthermore, we computed partial correlations to include these potential confounding 
variables in our main analyses, i.e. the correlations between ventral striatal activation and 
apathy/diminished expression. The association between apathy and percent signal change in 
the left VS remained highly significant (r = -.52, p = .01) but not in the right VS (r = -.38, p = 
.08), when including all covariates stated above. In contrast, the correlation between 
diminished expression and percent signal change in the VS remained non-significant (left 
VS: r = -.16, p = .46; right VS: r = .15, p =.5). Importantly, neither VS activation nor apathy 
scores were related to the range of motion during data acquisition (MRD) (see Supplement 
table S1). Additionally, an exploratory analysis of correlations between VS activation and all 
BNSS items and additional psychopathological assessment measures were performed 
(Table S2, Table S3). Interestingly, these data revealed that the association of apathy with 
reduced VS activation was strongest for the avolition subscale (left VS: r = -.53, p <.01; right 
VS r = -.44, p <.05). 
 
3.3.3. Reward Outcome Processing: VS, mOFC 
Significant ventral striatal activation related to reward magnitude were observed in patients 
with schizophrenia (left VS: cluster size = 40, t = 4.4; right VS: cluster size = 31 t = 4.2 both p 
< .05, FWE corrected) but not in healthy controls. Group comparison showed a significant 
differences in ventral striatal activation in the right VS (cluster size = 38, t = 4.4, p <.05 FWE 
corrected). In contrast, healthy controls and patients exhibited significant activation in the 
mOFC associated with reward magnitude (HC: cluster size = 39, t = 4.5; SZ: cluster size = 
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400, t = 4.9, both p < .05, FWE corrected) (Figure 4). The group comparison did not reveal 
any significant differences in the reward responses in the mOFC. Importantly, all significance 
level remained unchanged when including composite the cognitive ability score as covariate. 
 
3.3.4. Correlation between Outcome Processing and Negative Symptoms 
There were no significant correlations between the two negative symptom dimensions and 
VS or mOFC responses to reward magnitude. Furthermore, we observed no significant 
association between reduced activations of these regions and positive or depressive 
symptoms.  
 
 
4. Discussion 
In line with our a priori hypothesis we observed a strong association of reduced striatal 
activation during reward anticipation with apathy but not with diminished expression. To our 
knowledge, this is the first study showing a differentiation of apathy and diminished 
expression on a neurobiological level. At a behavioral level, previous work by our own group 
and others employing effort based decision making has already provided evidence for 
different pathophysiological mechanisms underlying the two main negative symptom 
dimensions 11,12,51. In a recent study, motivational deficits in schizophrenia, as measured by a 
progressive ratio task, were associated with clinical amotivation and neural hypoactivation of 
the VS 30. The present study extends this work by providing a specific link between the 
clinical expression of apathy and dysfunctional striatal reward anticipation, which strongly 
supports the hypothesis of different neural bases for apathy and diminished expression 34. In 
this context, our present findings highlight the importance of assessing both negative 
symptom domains separately when investigating the neural basis of negative symptoms 
1,7,8,34. 
 
For the study of apathy it is crucial to account for secondary negative symptoms, which are 
related to medication side effects, as well as positive psychotic and depressive symptoms 
52,53. We aimed to reduce the potential influence of secondary negative symptoms on our 
main findings with the following approach: First, we excluded patients at high risk of 
displaying secondary negative symptoms, i.e. all patients were clinically stable and showed 
no signs of major depression, no more than moderate positive symptoms and no signs of any 
extrapyramidal side effects. Second, none of the measures for potential causes of secondary 
negative symptoms were significantly correlated with ventral striatal activation. Third, the 
negative correlation between apathy and ventral striatal activation remained highly significant 
after controlling for all covariates. In addition, the association of apathy and reduced ventral 
striatal activation was also not influenced by cognitive ability.  
Importantly, the negative association with apathy was strongly related to the VS during 
reward anticipation. A correlation of apathy with activation related to the magnitude of 
received reward was neither observed in the VS nor in the mOFC. Preclinical studies have 
consistently emphasized that neurotransmission in the midbrain dopamine system, 
particularly the projections to the dorsal and ventral striatum mediates incentive motivation or 
“wanting” of reward 17,34,54. Furthermore, dopamine depletion or antagonism in the VS leads 
animals to choose a high effort option for larger rewards less often even though preferences 
for larger rewards remain intact in the absence of effort requirements 34,55. Conversely, 
administration of amphetamine in the VS, or genetic mutations, amplifying the extracellular 
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dopamine levels, contribute to an increase in “wanting” and motivated behavior 56,57. Human 
fMRI studies have shown a critical role of the ventral striatal activation during reward 
anticipation and its relationship to negative symptoms in schizophrenia 23,23,25,27–29. Now, our 
findings directly demonstrate for the first time that the association of VS hypofunction with 
apathy is significantly stronger than the association with diminished expression. Hence, we 
argue that hypoactivation in the VS reflects a disrupted “wanting” of reward, which 
contributes to a reduction of motivated behavior and is eventually expressed as apathy on 
the clinical and psychopathological level. 
 
At the group level, there were no significant differences between patients with schizophrenia 
and healthy controls in neural activation in the VS during reward anticipation, which is in line 
with most but not all previous studies 18,24,25,28,29. One potential explanation of this observation 
is the fact that all patients in our study were treated with atypical antipsychotics. Thus, our 
findings are in line with results of Schlagenhauf and colleagues emphasizing an improvement 
of reduced ventral striatal activity in patients on atypical but not on typical antipsychotics and 
of Juckel and colleagues showing reduced VS activation in patients treated with typical but 
not atypical antipsychotics 18,24. Furthermore, our results suggest an alternative explanation. 
We observed that neural activity in the VS during reward anticipation is negatively correlated 
with the severity of apathy in schizophrenia. Thus, patients with low expression of apathy 
may have intact neural activity in the VS during reward anticipation, which in turn limits the 
observed difference in group comparisons.  
 
Our finding of an intact mOFC response during receipt of reward is in line with previous 
imaging studies 19,27,28. Furthermore, we did not find any association of mOFC activation with 
the apathy dimension. This could be interpreted as an “intact in-the-moment experience” or 
“hedonic response” in apathy as recently proposed by various authors 14,58. However, it has 
to be acknowledged that our task was not designed to assess whether a prefrontal 
hypofunction contributes to apathy in addition to ventral striatal dysfunction.  
 
4.1. Limitations 
Although the present results provide strong evidence of the association of ventral striatal 
dysfunction during reward anticipation and apathy in schizophrenia, it is important to note 
some limitations. First, to fully support the hypothesis of different neural bases of apathy and 
diminished expression, a double dissociation would have to include neural correlates of 
diminished expression in addition to those for apathy presented here. Second, although in 
our analyses antipsychotic dose did not have any statistical effect, it would be important to 
investigate whether our findings can be generalized to unmedicated patients and patients 
treated with first generation antipsychotics. Third, screening for potential causes of 
secondary negative symptoms led to low variance in positive and depressive symptoms, 
which might be responsible for the lack of an association of these symptoms with reduced 
ventral striatal activation during reward anticipation. Thus, specificity with respect to these 
symptom dimensions cannot be inferred from the present study. Likewise, the positive 
correlation of depressive symptoms with ventral striatal activity during reward anticipation 
has to be considered in the light of this limitation and should not be overinterpreted. 
Concerning the analyses of the reward outcome we have to acknowledge that the MID task 
often does not produce robust neural signal of the VS during the outcome phase as observed 
in healthy controls in the present study. Therefore, our finding of a lack of correlation 
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between ventral striatal activation related to reward outcomes and apathy should not be 
overinterpreted. 
 
4.2. Conclusions 
In conclusion, the specific correlation of ventral striatal hypoactivation and apathy provides 
strong evidence for different underlying pathophysiological mechanisms of the two negative 
symptom domains. Our findings contribute to a multilevel framework, in which apathy and 
motivational impairment can be described on psychopathological, behavioral and neural 
levels as proposed in the Research Domain Criteria approach 59. Ventral striatal 
hypoactivation could be a potential “neuroimaging marker” for pharmacological treatment 
trials aiming at negative symptoms, which could help to further elucidate the mechanisms 
underlying treatment effects. 
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Tables 
Table 1 
Demographic, Psychopathological and Clinical Data    
 
Patients with 
Schizophrenia 
(n = 27) 
Healthy 
Controls 
(n = 25) 
Test Statistic 
(t/x2/U) p Value 
Age 31.9 (7.1) 33.0 (9.7) U = 322.00 .78 
Gender (f ,m) 9f, 18m 9f, 16m x2 = .04 .81 
Education, Years 12.2 (3.0) 12.4 (3.6) U = 334.00 .95 
Duration of Illness, Years 9.2 (6.6)    
Age of Onset, Years  22.7 (6)    
Chlorpromazine Equivalents (mg/d) 491.3 (349.5)    
BNSS Apathy (Motivation and 
Pleasure) 14.8 (6.8)    
BNSS Diminished Expression 9.8 (7.4)    
SANS Apathy * 12.8 (5.1)    
SANS Expression * 12.6 (10.7)    
PANSS Positive Factor † 6.6 (2.5)    
PANSS Negative Factor † 13.6 (5.2)    
PANSS Disorganized Factor† 4.5 (2.2)    
PANSS Excited Factor† 5.1 (1.5)    
PANSS Depressed Factor† 5.1 (2.2)    
PANSS Total† 49.4 (11.2)    
CDSS Total 1.5 (2.2)    
GAF 56.9 (9.6)    
PSP Total 56.4 (9.9)    
Cognition ‡ 
Composite Cognitive Ability 
 
-.61 (.89) 
 
0 (.53) 
 
t = 3.0 
 
.01§ 
MWT IQ 25.9 (5.8) 27.6 (4.0) t = 1.2 .23 
Note: Data are presented as means and standard deviations. Potential group differences were 
investigated using 2-sample t-tests for continuous and chi-square tests for categorical data. For non-
normally distributed data Mann-Whitney U tests were applied. All patients were receiving atypical 
antipsychotics at the time of testing. BNSS, Brief Negative Symptom Scale; CDSS, Calgary Depression 
Scale for Schizophrenia; GAF, Global Assessment of Functioning; MWT IQ, Multiple Word Test 
Intelligence Quotient; PANSS, Positive and Negative Syndrome Scale; PSP, Personal and Social 
Performance Scale; SANS, Scale for the Assessment of Negative Symptoms. 
* Apathy = Avolition/Apathy, Anhedonia/Asociality; Diminished Expression = Affective Flattening or 
Blunting, Alogia. 
† Positive Factor = P1, P3, P5, G9; Negative Factor = N1, N2, N3, N4, N6, G7; Disorganized Factor = P2, 
G5, N11; Excited Factor = P4, P7, G8, G14; Depressed Factor = G2, G3, G6 
‡ Cognition data have been z-transformed based on the data of the HC group for each test separately. The 
Composite Cognitive Ability score was computed as the mean of the z-transformed test scores on subject 
level. 
§ p < .05  
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Table 2 
 
Behavioral Data of the Variant of the Monetary Incentive Delay Task 
 
Patients with 
Schizophrenia 
(n = 27) 
Healthy 
Controls 
(n = 25) 
Test 
Statistic 
(t/U) 
p Value 
response time, no reward 555.4 (111.0) 519.2 (81.0)   
response time, low reward 539.4 (106.1) 490.3 (78.6)   
response time, high reward 505.3 (102.7) 467.5 (80.6)   
error trials, total 6.3 (4.4) 5.7 (4.0) U = 313.5 .66 
total gain (in CHF) 36.0 (4.6) 38.9 (5.2) t = 2.1 .04* 
Note: Data are presented as means and standard deviations. Response time is presented in 
milliseconds. CHF, Swiss Francs. . Potential group differences were investigated using 2-sample t-
tests for continuous data. For non-normally distributed data Mann-Whitney U tests were applied. 
* p < .05 
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Figures 
 
Figure 1 
 
 
 
Figure 1. Variant of the Monetary Incentive Delay Task. First, participants saw one of three 
cues indicating the amount of money they could win, if they reacted correctly during the 
following discrimination task. Immediately after target presentation, a visual feedback 
informed the participants about the amount of money they had won during the trial. We used 
a column ranging from minimal (CHF 0) to maximal win amount (CHF 2.0). A red horizontal 
line indicated the amount of money won during the respective trial.  
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Figure 2 
 
 
 
Figure 2. Within group activation maps of the contrast anticipation of high reward vs no 
reward in the VS (p < .05 FWE corrected). The within group t maps (depicted in cyan) were 
overlaid on the ROI (shown in dark yellow). (A) Coronal and (B) axial contrast images of 
healthy controls. (C) Coronal and (D) axial contrast images of participants with 
schizophrenia.  
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Figure 3 
 
 
 
Figure 3. Bivariate Pearson correlation (including significance test) of apathy (A) and 
diminished expression (B) with percent signal change in the left VS in participants with 
schizophrenia. Percent signal change in the left VS in healthy controls (C). 
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Figure 4 
 
 
 
Figure 4. Within group activation maps of the parametric modulator of high reward outcome 
processing in mOFC (i.e. activation associated with the amount of reward actually received) 
(p < .05 FWE corrected). The within group t maps (depicted in cyan) were overlaid on the 
ROI (shown in dark yellow). (A) Sagittal (B) axial contrast images of healthy controls. (C) 
Sagittal and (D) axial contrast images of participants with schizophrenia.  
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Supplementary Materials 
 
Supplementary Methods 
 
1.1 Participants 
All inpatients included in the present study were at the end of their hospitalization, 
participated in a multimodal treatment program and engaged in activities outside the hospital, 
allowing us to assess negative symptoms. Please note that in Switzerland, the average 
duration of inpatient treatment of patients with schizophrenia is approximately 40 days 1, 
which means that most of our inpatients would have been treated as outpatients in other 
health care systems. 
 
1.2. Clinical and Neuropsychological Assessment 
German Version of the BNSS 
We used the German Version of the BNSS translated by the senior author and controlled 
through back-translation to English by a BNSS naïve, English native speaker and 
psychiatrist. Assessment of inter-rater reliability showed an excellent intra-class correlation 
coefficient (ICC) of 0.97 for the BNSS total score and ICCs from 0.87 to 0.97 for the 
subscales.  
 
Neuropsychological test battery 
Healthy controls and individuals with schizophrenia performed a neuropsychological test 
battery assessing verbal learning (Auditory Verbal Learning Memory Test) 2, verbal and 
visual short-term working memory 3 and corsi block-tapping test 4, processing speed (Digit-
Symbol Coding) 5, planning (Tower of London) 6 and semantic and phonetic fluency (animal 
naming, s-words) 7. Results of all cognitive tests were summarized in a composite cognitive 
ability score computed with the mean of z-transformed scores (based on HC group data). 
Additionally, we used the Multiple Word Test 8 to control for premorbid verbal intelligence. 
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1.3. Figure S1: Graphical illustration of pay-out structure 
 
 
 
Figure S1. Pay-out structure of variant of the Monetary Incentive Delay task. For every 
individual we calculated the 15 previous reaction times and sorted them from fast to slow 
using a simple bubble sorting procedure. We then selected the reaction times corresponding 
to the 60th percentile and 80th percentile, defining a minimum and maximum of the time range 
within each participant had to react in order to win money (grey area = time range 0 to 1). 
Due to the fact that these ranges tended to be low (~5 to 10 milliseconds), we dispersed the 
time frame, ranging from -2.5 ranges below the original minimum and 1 range above the 
original maximum. Finally, the pay-out amount was determined by plotting the amount won in 
each respective trial with this modified dispersion of the original time range. With respect to 
the pay-out structure this approach allowed the task to possess a “realistic feel” by providing 
more dispersed outcome amounts. The X-axis represents the corresponding percentage of 
the maximal possible win during each trial. For example: in order to win CHF 0.8 during the 
CHF 2 condition, participants had to react -1 ranges below the minimum, in order to win CHF 
1.6, the reaction time had to be 1 range above the minimum. 
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Supplementary Results 	
2.1. Mean response times and reward-related speeding during experimental conditions 
 
Figure S2. Mean response time (presented in milliseconds) for all three conditions, presented 
for healthy participants and patients with schizophrenia separately. Data were analyzed 
using a two-way repeated measures ANOVA with group as between-subject factor and 
reward condition (neutral, low, high) as within-subject factor. 
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Table S1. Bivariate correlation of mean relative displacement (MRD) of head motion 
during data acquisition and ventral striatal activation during reward anticipation and 
apathy score in individuals with schizophrenia 
 MRD 
(head motion) 
Ventral striatal Activation during reward anticipation  
VS left -.12 
VS right -.08 
Psychopathology  
BNSS apathy .20 
Note: According to van Dijk et al.9 measurement of in-scanner head motion was 
calculated as mean relative displacement between adjacent volumes. Mean 
displacement was computed as the root-mean-square of translational parameters 
(displacement = square root ((x2)+(y2)+(z2)). Number of movements were n-1 (n = 195 
volumes). 
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Table S2. Bivariate correlation of BNSS subscales and individual BNSS items with 
ventral striatal activation during reward anticipation in individuals with schizophrenia 
BNSS subscales and individual items Percent signal 
change in left VS 
during reward 
anticipation 
Percent signal change 
in right VS during 
reward anticipation 
Anhedonia -,29 -.25 
BNSS 1 -.27 -.21 
BNSS 2 -.25 -.23 
BNSS 3 -.32 -.29 
Social Withdrawal -.33 -.22 
BNSS5 -.30 -.17 
BNSS6 -.32 -.24 
Avolition -.53† -.44* 
BNSS 7 -.46* -.36 
BNSS 8 -.52† -.46* 
Affective Blunting .01 .11 
BNSS 9 -.13 -.03 
BNSS 10 -.16 -.10 
BNSS 11 -.09 -.01 
Alogia .02 .08 
BNSS 12 .02 .08 
BNSS 13 .01 .08 
*P < .05. †p< .01 
 
  
Appendix 
	 	 	 78 
 
Table S3. Bivariate correlation of additional psychopathological and clinical assessment 
measures with ventral striatal activation during reward anticipation in individuals with 
schizophrenia 
 Percent signal change 
in left VS 
during reward 
anticipation 
Percent signal change 
in right VS 
during reward 
anticipation 
Psychopathology   
SANS apathy -.42* -.26 
SANS expression -.05 .06 
PANSS positive factor -.23 -.17 
PANSS negative factor -.08 .02 
CDSS (total) .45* .34 
GAF (total) .25 .09 
PSP (total) .16 -.003 
Note: Abbreviations are explained in the first footnote to tables 1. 
. *P < .05. 
 
To test for potential differences between the two correlations of VS activation and SANS 
apathy and VS activation and SANS expression we performed the Steiger test for dependent 
correlation coefficients. We found significant differences between these correlations in the 
left VS (tDiff = 2.2, p = .03) but not in the right VS (tDiff = 1.8, p = .07). 
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Abstract: 
The negative symptoms of schizophrenia have been associated with altered neural activity 
during both reward processing and cognitive processing. Even though increasing evidence 
suggests a strong interaction between these two domains, it has not been studied in relation 
to negative symptoms. To elucidate neural mechanisms of the reward-cognition interaction, 
we applied a letter variant of the n-back working memory task and varied the financial 
incentives for performance. In the interaction contrast, we found a significantly activated 
cluster in the rostral anterior cingulate cortex (ACC), the middle frontal gyrus, and the 
bilateral superior frontal gyrus. The interaction did not differ significantly between the patient 
group and a healthy control group, suggesting that patients with schizophrenia are on 
average able to integrate reward information and utilize this information to maximize 
cognitive performance. However within the patient group, we found a significant inverse 
correlation of ACC activity with the factor diminished expression. This finding is consistent 
with the model that a lack of available cognitive resources leads to diminished expression. 
We therefore argue that patients with diminished expression have difficulties in recruiting 
additional cognitive resources (as implemented in the ACC) in response to an anticipated 
reward. Due to this lack of cognitive resources, less processing capacity is available for 
effective expression, resulting in diminished expressive behavior.  
 
 
 
Key words:  diminished expression, apathy, emotion-cognition interaction, reward 
anticipation, anterior cingulate cortex 
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1. Introduction 
Negative symptoms – comprising the domains of blunted affect, alogia, asociality, 
anhedonia, and avolition – are an integral component of schizophrenia. They are a strong 
predictor of poor prognosis and contribute to functional impairment (Azorin et al., 2014; 
Kirkpatrick et al., 2006; Milev et al., 2005; Rabinowitz et al., 2012). A recent consensus 
suggests that negative symptoms can be grouped into two factors. One factor is referred to 
as diminished expression, comprising blunted affect and alogia. The other factor is referred 
to as diminished motivation and pleasure, or apathy, and comprises asociality, anhedonia 
and avolition (Kring and Barch, 2014; Strauss et al., 2012). This distinction might allow a 
more differentiated approach in the search of underlying pathophysiological mechanisms 
(Blanchard and Cohen, 2006; Foussias and Remington, 2010; Liemburg et al., 2013; 
Messinger et al., 2011).  
 
Negative Symptoms have been consistently associated with dysfunctional reward 
processing, in particular with diminished reward anticipation. On a neural level, this has been 
linked to a reduction in ventral striatal activity (Juckel et al., 2006; Nielsen et al., 2012; 
Schlagenhauf et al., 2008; Simon et al., 2010; Waltz et al., 2008). Negative symptoms have 
also been linked to neurocognitive deficits, although this association is rather modest (Lin et 
al., 2013; Milev et al., 2005; Ventura et al., 2013, 2009). The cognitive deficits, and to a 
lesser extent negative symptoms, have been associated with abnormal activity in the 
prefrontal cortex, particularly the dorsolateral prefrontal cortex (dlPFC; Barch and Ceaser, 
2012; Manoach, 2003).  
 
Recent work suggests that there is a strong interaction of reward anticipation with cognitive 
performance. Knowing that a certain cognitive effort might result in the receipt of a reward 
leads to the prioritization of the respective process and influences the assignment of limited 
cognitive resources (Beck et al., 2010; Braver et al., 2014; Kennerley and Wallis, 2009; 
Krawczyk et al., 2007; Locke and Braver, 2008; Rowe et al., 2008). On the neural level, the 
anterior cingulate cortex (ACC) has been suggested to play an essential role in this 
interaction and to act as a hub linking reward and cognition (Krebs et al., 2012; Pessoa, 
2009, 2008; Vassena et al., 2014). It is presumed that the ACC receives reward information 
from the ventral striatum (VS), thereby enhancing cognitive performance (Holroyd and 
Yeung, 2012; Pessoa, 2009; Steenbergen et al., 2014). It remains unknown how negative 
symptoms in schizophrenia relate to the reward-cognition interaction at the neural level. 
 
In the current study, we measured cognitive performance with a letter variant of the n-back 
working memory (WM) task and varied the financial incentives for the performance. We 
hypothesized that patients with schizophrenia would show impairments in the modulation of 
cognitive performance by reward and that these impairments are correlated with the severity 
of negative symptoms. On a neural level, we expected that the prospect of a future reward 
leads to the activation of the ACC as well as to a stronger activation in WM related regions in 
the lateral PFC. We expected that these effects are diminished in the patient group and show 
an inverse correlation with the severity of negative symptoms. 
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2. Methods 
2.1. Participants 
We studied 29 individuals meeting Diagnostic and Statistical Manual of Mental Disorders 
(DSM-IV; American Psychiatric Association, 2000) criteria for schizophrenia (n=23) or 
schizoaffective disorder (n=6) and 27 healthy control subjects with no personal history of a 
DSM-IV axis 1 disorder. All participants provided written informed consent to participate in 
the study, which was approved by the local Ethics committee. Patients were recruited either 
as inpatients (n=16) or outpatients (n=13) from the Psychiatric Hospital, University of Zurich, 
or from affiliated institutions. All inpatients were at the end of their hospitalization and they 
participated in a multimodal treatment program that encouraged them to engage in daily 
activities outside the hospital. All patients received constant doses of medication for at least 
two weeks prior to testing, with the exception of one patient receiving a small increase of 
clozapine dose seven days before testing. Exclusion criteria included a daily lorazepam 
dosage greater than 1mg, florid positive symptoms, i.e. any positive subscale item score of 
the Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987) >4, extrapyramidal 
side effects, measured with the Modified Simpson-Angus Scale (MSAS; Simpson et al., 
1970), >3, or any other DSM-IV axis 1 diagnosis. For confirmation, all participants were 
assessed using the Mini-International Neuropsychiatric Interview (M.I.N.I.; Sheehan et al., 
1997). 
 
2.2. Clinical and neuropsychological assessment 
All patients were further assessed using the Brief Negative Symptom Scale (BNSS; Strauss 
et al., 2012), the Scale for the Assessment of Negative Symptoms (SANS; Andreasen NC, 
1982), the PANSS, the Global Assessment of Functioning scale (GAF; Frances et al., 1994), 
the Personal and Social Performance Scale (PSP; Schaub and Juckel, 2011) and the 
Calgary Depression Scale for Schizophrenia (CDS, Addington et al., 1993). We used the 
BNSS as our main measurement for negative symptoms since it was designed to facilitate a 
clear distinction of the factors apathy and diminished expression. For the total BNSS score, 
the assessment of the inter-rater reliability showed an intra-class correlation coefficient (ICC) 
of 0.97. The subscales reached ICCs from 0.87 to 0.97. 
 
To characterize the sample and to disentangle the effects of neuropsychological functioning, 
the following cognitive domains were tested: verbal learning (Auditory Verbal Learning 
Memory Test, VLMT; Helmstaedter and Durwen, 1990), verbal and visual short-term working 
memory (Digit Span, DS; Stieglitz, 2000) and Corsi block-tapping test (CBT; Kessels et al., 
2000), processing speed (Digit-Symbol Coding, DSC; Von Aster et al., 2006), planning 
(Tower of London, ToL; Shallice, 1982), and semantic and phonetic fluency (animal naming, 
AN; s-words, SW; Delis et al., 2001). 
 
2.3. Functional magnetic resonance imaging 
2.3.1. Imaging acquisition 
Two runs containing 185 whole brain T2* weighted echo-planar images (EPI) were acquired 
in ascending order using a Philips Achieva 3.0T magnetic resonance scanner with a 32 
channel SENSE head coil (Philips, Best, The Netherlands). Further specifications were: 
3x3x3mm3 in-plane resolution, 0.5mm gap width, 240x240mm field of view, 2000ms TR, 
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25ms TE, flip angle 82°. Slices were aligned with the anterior-posterior commissure. The first 
five scans were discarded to eliminate the influence of T1 saturation effects. A T1-weighted 
high-resolution anatomical scan was obtained for registration: 160 sagittal plane slices, 
1x1x1mm3. 
 
2.3.2. Task and stimuli 
A modified version of a previously employed letter n-back task was used (Owen et al., 2005; 
Pochon et al., 2002). The task was presented as a two by two factorial design with the 
factors cognitive load (0-back vs. 2-back) and reward (reward vs. no reward), resulting in a 
total of four different conditions: 0-back/reward (0R), 0-back/no reward (0N), 2-back/reward 
(2R), 2-back/no reward (2N) (see figure 1).  
 
--- Insert figure 1 here --- 
 
2.3.3. Behavioral analyses 
The sensitivity index d’ (Haatveit et al., 2010; Green, 1988) and reaction times were used to 
analyze the behavioral performance. D’ is calculated as the standardized probability of a hit 
minus the standardized probability of a false alarm: d’ = z(probability(hits)) – 
z(probability(false alarms)). To test for differences in behavioral performance, d’ and reaction 
times were entered into separate mixed-design ANOVAs with group (patient group, healthy 
control group) as between-subjects factor and cognition (0-back, 2-back) and reward (no 
reward, reward) as within-subject factors. To relate behavioral performance to 
psychopathological ratings of negative symptoms, we calculated Pearson’s r. All analyses 
were performed using IBM SPSS Statistics Version 21.  
 
2.3.4. fMRI analyses 
Functional MRI data were analyzed using SPM8 (Statistical Parametric Mapping, Wellcome 
Department of Cognitive Neurology, London, UK). Differences in EPI slice acquisition timing 
were corrected using the central slice as reference. To reduce artifacts from head 
movements, functional images were realigned using a least squares approach and a six-
parameter rigid body spatial transformation, using the first image as a reference. A voxel 
displacement map, calculated from double phase and magnitude field map data, was applied 
for a combined static and dynamic distortion correction. After co-registration, the “New 
Segment” toolbox was used for spatial normalization. Finally, images were smoothed using a 
Gaussian kernel of 6 mm width. 
 
For our block design, we used a general linear model (GLM) with a two-stage approach. On 
the first stage of analysis, two levels of cognitive load (0-back/2-back) and two levels of 
reward (reward/no reward) were modeled. To study the cognition/reward interaction effect, 
i.e., the effect of reward-dependent modulation of working memory, the following contrast 
images were constructed: ((2-back/reward) – (0-back/reward)) – ((2-back/no reward) – (0-
back/no reward)). These images were taken to the second stage of analysis for random-
effects inference.  
 
Due to our a priori hypothesis, we restricted our search volume to the PFC and ACC (Barch 
and Dowd, 2010; Cai and Padoa-Schioppa, 2014; Kaping et al., 2011; Kennerley and Wallis, 
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2009; Kennerley and Walton, 2011; Watanabe, 2007). We used the Automated Anatomical 
Labeling (AAL; Tzourio-Mazoyer et al., 2002) atlas implemented in the WFU_PickAtlas 
toolbox (Maldjian et al., 2004, 2003) for SPM and included the following bilateral regions to 
construct one single search volume: the dorsolateral and superior frontal gyrus, the (orbital) 
middle frontal gyrus, the opercular, triangular and orbital inferior frontal gyrus, the medial 
superior frontal gyrus, and the anterior part of the cingulate gyrus. Within our restricted single 
volume of interest, the statistical threshold was set to FWEp=0.05. Cluster extend was 
calculated based on p<.001 uncorrected.  
 
To relate brain activation with psychopathological ratings in the patient group, we extracted 
mean beta values in the interaction contrast based on the activated clusters in the healthy 
control group using the REX toolbox (Whitefield-Gabrieli, 2009) and performed simple 
correlation analyses.  
 
For exploratory purposes we also extracted parameter estimates in the activated clusters in 
the whole group (i.e. combined patients and controls) interaction contrast and calculated 
correlations with negative symptoms.  
 
 
3. Results 
3.1. Sample Characteristics 
Demographic and clinical data are summarized in table 1. There were no significant group 
differences with regard to age, gender, handedness, and education. As expected, we found a 
significant group difference in the composite score of all cognitive tests. The healthy control 
group performed significantly better than the patient group. However, we found no significant 
difference in the test scores measuring working memory performance (see below). 
 
--- Insert table 1 here --- 
 
3.2. Behavioral Data 
In the n-back task, the main effect of group on sensitivity was not significant, F(1,54)=.955, 
p=.333. Pooling over all subjects, we found a significant main effect of the factor cognition on 
sensitivity, F(1,54)=7.514, p=.008. Participants performed significantly better in the 0-back 
condition (𝑥=7.05, SD=.61) relative to the 2-back condition (𝑥=6.65, SD=.93), meaning that 
the d’ is significantly higher in the 0-back condition relative to the 2-back condition. The main 
effect of the factor reward on accuracy and the interaction of cognition and reward was not 
significant, F(1,54)=.060, p=.808 and F(1,54)=.338, p=.563, respectively. All other 
interactions were also non-significant. We did not find any significant correlation between 
sensitivity and psychopathological ratings. 
 
With regard to reaction times, we found a main effect of group, F(1,54)=4.633, p=.036, 
indicating that healthy control subjects were faster than patients with schizophrenia across 
conditions. Furthermore, across all subjects, we found a main effect of the factor cognition, 
F(1,54)=43.789, p<.001, indicating that participants were significantly faster in the 0-back 
condition (𝑥=468.03, SD=65.04) relative to the 2-back condition (𝑥=546.64, SD=110.63). We 
also found a main effect of the factor reward, F(1,54)=8.656, p=.005, showing that 
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participants speeded up in the rewarded trials (𝑥=499.09, SD=81.38) relative to the non 
rewarded trials ( 𝑥 =515.58, SD=82.47). The reward-cognition interaction, F(1,54)=.007, 
p=.935, as well as all other interactions were not significant. Furthermore, we found a 
significant positive correlation of BNSS apathy with the mean reaction time of the 2back 
condition relative to the 0back condition (r=.38, p=.042) and with the mean reaction time of 
the reward-cognition interaction (r=.38, p=.041). All other correlations between reaction time 
and negative symptom scores were non-significant.  
 
--- Insert table 2 here --- 
 
3.3. Imaging Data 
In the whole group reward-cognition interaction contrast, we found significant activation 
within our volume of interest in the right superior frontal gyrus (rSFG; x=17, y=21, z=58; 
k=910, t=6.13, FWEp<.001), the left superior frontal gyrus (lSFG; x=-18, y=33, z=42, k=567, 
t=5.33, FWEp<.001), the right rostral cingulate cortex (rACC; x=9, y=44, z=1, k=1018, t=5.32 
FWEp<.001), and the medial superior frontal gyrus (mSFG; x=8, y=68, z=18, k=267, t=5.15, 
FWEp<.001), when working memory performance was rewarded compared to when it was 
not rewarded (see figure 2A). These regions could therefore be involved in integrating reward 
and cognition.  
 
Next we looked at the groups separately and tested for activation differences. Within the 
healthy control group, we found a cluster in the right rostral anterior cingulate cortex (rACC; 
x=9, y=44, z=1, k=88; t=5.91, FWEp=.047) that showed significantly more activation in the 
interaction contrast (see figure 2B). This cluster was further used for our correlation 
analyses. The according parameter estimates can be found in the supplement 
(supplementary figure 1). The patient group showed significant activation in the right superior 
frontal gyrus (rSFG; x=23, y=15, z=55; k=661; t=7.21, FWEp=.002) within this interaction 
contrast (See figure 2C). However, we did not find any significant differences between the 
two groups, in line with the absence of a behavioral difference.  
 
In addition to the analysis in our a priori defined volume of interest, we also performed a 
whole brain analysis using the same statistical thresholds (see supplementary table 1), which 
did not reveal any additional clusters. 
 
--- Insert Figure 2 here --- 
 
3.4. Correlation analyses 
Within the patient group, ACC activation in the reward-cognition interaction contrast 
correlated negatively with BNSS diminished expression (r(29)=-.393, p=.035). The 
correlation with SANS diminished expression reached trend-level significance (r(29)=-.365, 
p=.052). In contrast, the correlation between percent signal change in the ACC and BNSS 
apathy as well as SANS apathy did not reach significance (r(29)=-.015, p=.937, and r=-.001, 
p=.998, respectively; see figure 3).  
 
To test for a difference between these two dependent correlations, we performed a Steiger’s 
Z-test, which revealed that the correlation between BNSS diminished expression and percent 
signal change was significantly different from the correlation between BNSS apathy and 
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percent signal change (Z=-2.04, p=.041). To confirm that other potentially confounding 
variables, i.e., depressive symptoms, chlorpromazine equivalents, and age, did not account 
for the correlation between BNSS diminished expression and activity in the ACC, we 
computed a partial correlation with the factors above included. The association between 
diminished expression and ACC activation remained significant (r(24)=-.402, p=.042). 
 
--- Insert Figure 3 here --- 
 
Furthermore, we also found a significant correlation of ACC activation and BNSS diminished 
expression (r(29)=-.434, p=.019) when we defined the clusters based on the whole group 
(i.e. combined patients and controls) analysis, which underlines the robustness of this finding 
(see supplementary table 2). No other cluster from the whole group analysis showed a 
significant correlation with negative symptom dimensions. 
We additionally performed an exploratory whole-brain ANCOVA with the standardized BNSS 
measures (diminished expression and apathy) as covariates in a whole brain analysis, but 
this analysis did not reveal any significant clusters. 
 
 
4. Discussion 
To our knowledge, this is the first study to investigate the neural effects of reward modulation 
on working memory in patients with schizophrenia and healthy controls. On the neural level, 
we found evidence that reward modulation influences working memory in both groups. In the 
patient group, we found a negative correlation of activity in the ACC with the negative 
symptom factor diminished expression, but not with the factor apathy.  
 
Across all subjects, our behavioral data suggest that participants processed both cognitive 
and reward factors of the task. We further found that apathy was significantly correlated with 
the reaction time in the 2back relative to the 0back condition and in the in the reward-
cognition interaction, indicating that cognitive load and the integration of complex information 
reduces reaction time in apathetic patients. On the neural level, the reward-cognition 
interaction led, among others, to significant activation of the rostral ACC. This region has 
been suggested to play an important role in controlling current demands, which are 
influenced by the presence of a potential reward or punishment (Holroyd and Yeung, 2012; 
Pessoa, 2009, 2008; Pessoa and Engelmann, 2010; Steenbergen et al., 2014). It is further 
assumed that the signal from the ACC is used to guide behavior via dense interconnections 
with cortical areas, such as the (pre-) motor cortex and the DLPFC (Haber and Knutson, 
2009). In line with this hypothesis, we also observe three PFC clusters in the reward-
cognition interaction contrast, which are part of the working memory network. Due to the 
reward at stake, the cognitive process leading to the harvest of the reward is prioritized, and 
cognitive resource capacities are allocated in order to maximize performance. Since we did 
not find any significant group differences, we believe that this process is generally functioning 
in patients with schizophrenia, at least at the relatively basic levels tested here. 
 
However, within the patient group, we found a significant inverse correlation of the negative 
symptom factor diminished expression with activity in the rostral ACC related to the reward-
cognition interaction. This correlation was specific for the factor diminished expression, 
because it was significantly different from the correlation with the factor apathy. The 
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correlation remained significant after controlling for confounding variables. Since the ACC 
has been proposed to play a crucial role in controlling resource distribution and behavioral 
adaptation, we hypothesize that patients with more severe negative symptoms, in particular 
diminished expression, have difficulties in regulating their limited available processing 
resources to meet the current demand (Holroyd and Yeung, 2012; Pessoa, 2009; 
Steenbergen et al., 2014).  
 
This idea is in line with the cognitive resource limitation model (Cohen et al., 2012, 2013, 
2014a, 2014b). Cohen proposes that effective expression requires a range of mental 
resources. If these limited resources are engrossed by another task or process, they are not 
available for expressive behavior. Considering that patients with schizophrenia have lower 
cognitive abilities compared to healthy controls, the effects are magnified, since fewer 
resources are available in the first place. Our data suggest that patients with more 
pronounced diminished expression do not only have less cognitive resources available as 
proposed by Cohen (2012, 2013, 2014), but that they have a specific problem in adjusting 
resources according to their priority. In other words, potential reward fails to recruit additional 
cognitive resources, which in turn leads to diminished expressive behavior. 
 
There are several limitations to our study. Since this was the first study to investigate the 
neural correlates of reward-cognition interaction, the hypotheses were relatively broad. Thus, 
the study has to be considered exploratory and requires replication. Furthermore, although 
the antipsychotic medication did not have any statistical effects, further studies should 
elucidate whether these results can be generalized to unmedicated patients.  
 
In conclusion, we found a specific inverse correlation of rostral ACC activation with the factor 
diminished expression. To our knowledge, this is the first study showing a specific correlation 
of neural activity with this factor, supporting the notion of separable neural bases for the two 
negative symptom dimensions. These findings highlight the need to further investigate the 
complex interaction of reward processing and cognition, with a particular focus on the 
adaptation of cognitive resources in schizophrenia and the relation to diminished expression. 
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Tables 	
Table 1 
 Patient Group 
(n = 29) 
HC Group 
(n = 27) 
Test Statistic 
(t/Χ2/U) 
 
P 
Age in years 32.07 (7.26) 33.11 (9.02) t = .478 .64 
Gender (male/female) 20/9 17/10 χ2 = .225 .64 
Formal education in years 12.03 (3.08) 12.35 (3.45) U = 377.5 .82 
Duration of illness in months 174.03 (323.18) −   
Number of hospitalizations 5.07 (4.36) −   
Chlorpromazine equivalents (mg/day) 536.76 (400.96) −   
Psychopathology     
BNSS apathya 14.41 (7.22) −   
BNSS diminished expressiona 9.45 (8.06) −   
SANS apathyb 12.14 (5.13) −   
SANS diminished expressionb 11.90 (10.78) −   
PANSS positive factorc 6.52 (2.63) −   
PANSS negative factorc 13.74 (5.38) −   
GAF 57.41 (9.59) −   
PSP (total) 56.97 (9.81) −   
CDSS (total) 1.52 (2.18) −   
Cognition     
Composite cognitive abilityd -.45 (.78) 0 (.49) t = 2.583 .013 
CBS forward 8.17 (1.81) 8.56 (2.04) t = .743 .46 
CBS backward 7.66 (1.84) 7.96 (1.66) t = .653 .52 
DS forward 7.31 (2.04) 7.59 (1.72) t = .559 .58 
DS backward 6.55 (1.80) 6.22 (1.34) U = 359.5 .59 
Notes: Data are presented as means and standard deviations. For normally distributed continuous and categorical variables, 2-
sample t tests and chi-square were applied to test for potential group differences. If data were not normally distributed, Mann-
Whitney U tests were applied.  
All patients except one were receiving stable doses of atypical antipsychotic medication at the time of testing. Nine individuals 
were additionally receiving antidepressants, two were receiving mood-stabilizers, two patients were medicated against insomnia 
and one person was receiving a low dose of benzodiazepine 
BNSS, Brief Negative Symptom Scale; SANS, Scale for the Assessment of Negative Symptoms; PANSS, Positive and Negative 
Syndrome Scale; GAF, General Assessment of Functioning; PSP, Personal and Social Performance Scale; CDSS, Calgary 
Depression Scale for Schizophrenia; CBS, Corsi block span; DS, Digit span  
P values lower than .05 are in bold 
aApathy = Anhedonia, Asociality, Avolition; diminished expression = lack of normal distress, blunted affect, alogia 
bApathy = Avolition/Apathy, Anhedonia/Asociality; diminished expression = Affective Flattening or blunting, Alogia 
cPositive factor = P1, P3, P5, G9; negative factor = N1, N2, N3, N4, N6, G7 
dCognition data have been standardized based on the HC group  		 	
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Table 2 	
 Patient Group 
(n = 29) 
HC Group 
(n = 27) 
Accuracy    
0-back Reward 6.95 (.59) 7.13 (.80) 
0-back No Reward 7.15 (.48) 6.99 (.92) 
2-back Reward 6.48 (1.16) 6.90 (.68) 
2-back No Reward 6.54 (1.34) 6.70 (.98) 
Reaction Time   
0-back Reward 472.26 (72.88) 445.82 (52.49) 
0-back No Reward 495.57 (74.15) 456.14 (59.62) 
2-back Reward 564.43 (126.85) 511.02 (106.30) 
2-back No Reward 582.33 (109.68) 524.83 (114.86) 
Notes: Data are presented as means and standard deviations. Accuracy is measured as the 
standardized probability of a hit minus the standardized probability of a false alarm. Reaction time 
is measured in ms. 		  
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Figures 	
Figure 1 	
		
Figure 1. Schematic view of the modified letter n-back task. Each condition was presented 
four times, resulting in a total of 16 blocks. The 16 blocks were split into 2 runs. The order of 
presentation was equal for all subjects and as follows: 0R, 2R, 0N, 2N, 2N, 0N, 2R, 0R; 0R, 
0N, 2R, 2N, 2N, 2R, 0N, 0R. In the 0-back condition, participants had to press a button 
whenever a pre-specified letter appeared on the screen, i.e., the letter x. In the 2-back 
condition, participants were required to press a button whenever the letter they saw was 
equal to the letter presented before the last one. In the reward condition, participants earned 
a monetary reward according to their performance. The maximum payment per block was 5 
Swiss Francs (CHF) whereas the minimum payment was 0 CHF. The maximum payment for 
all 8 blocks was 40 CHF. Additionally, participants received a guaranteed amount of 10 CHF. 
In the no reward condition, the subjects did not receive any payment.  
 
After the indication of the current condition, a fixation cross followed (A & B). One block 
consisted of 12 letter stimuli containing 4 targets. Each letter appeared for 500ms and was 
followed by an intertrial interval of 1500ms (C). After the presentation of all 12 stimuli, a 
feedback about the performance and the monetary gain was given for 2500ms (D). A resting 
period of 12000ms followed after every block (E).  		 	
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Figure 2 	
		
Figure 2. Group activation maps of the contrast rewarded WM vs. non-rewarded WM: ((2-
back/reward – 0-back/reward) – (2-back/no reward – 0-back/no reward)) for all subjects (A), 
healthy controls (B), and patients with schizophrenia (C). The search volume was restricted 
to the PFC and ACC. Please note that there were no significant differences between groups. 
The statistical threshold was set FWEp = 0.05. The cluster extend was based on p < .001, 
uncorrected. 	 	
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Figure 3 	
		
Figure 3. Correlation between percent signal change in the ACC in the interaction contrast 
and diminished expression scores (A) and apathy scores (B). The two correlations differed 
significantly from each other, suggesting a stronger relation of diminished expression than 
apathy to the reward/cognition interaction. 
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Supplementary Results 
 
Whole brain analyses 
In the exploratory whole brain analysis in the reward-cognition interaction contrast 
across all subjects, we found significant activation in the right superior frontal gyrus (x 
= 17, y = 21, z = 58; k = 996, t = 6.13, FWEp < .01). Within the healthy control group, 
we did not find any significant activation. Within the patient group, we found 
significant activity in the right superior frontal gyrus (x = 22, y = 15, z = 56, k = 729, t 
= 7.21, FWEp < .01) and the middle occipital gyrus (x = -27, y = -89, z = 12, k = 
2824, t = 6.51, FWEp < .05). 
 
In the exploratory whole brain correlation analyses, we did not find any significant 
correlation of brain activity with negative symptoms. 
 
Correlation analyses based on whole group interaction contrast 
We extracted parameter estimates in the activated clusters in the whole group 
interaction contrast and calculated correlations with negative symptoms. As in our 
volume of interest analysis, we found a significant correlation of activity in the rACC 
with BNSS diminished expression, but not with BNSS apathy (see table below). 
 
 rSFG 
[17,21,58] 
lSFG 
[-18,33,42] 
rACC 
[9,44,1] 
mSFG 
[8,68,18] 
BNSS Dim. 
Expr. 
r = -.023 
p = .906 
r = -.057 
p = .767 
r = -.434 
p = .019 
r = -.204 
p = 289 
BNSS Apathy r = -.058 
p = .767 
r = .145 
p = .452 
r = .029 
p = .880 
r = -.030 
p = .879 
 
Supplementary Figure 
 
 
Supplementary Figure. Mean parameter estimates of the activation in the rACC separate for 
both groups under all conditions. 	 	
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Appendix C: Study 3 
 
M. Kirschner, O. Hager, M. Bischof, M. Hartmann-Riemer, A. Kluge, E. Seifritz, P. Tobler, 
and S. Kaiser, accepted for publication. Deficits in Context-dependent Adaptive Coding of 
Reward in Schizophrenia. npj Schizophrenia 
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Abstract: 
Background: A variety of impairments in reward-related processes in schizophrenia have 
been linked to deficits in the representation of rewards. However, it remains an open issue 
which neural mechanisms underlie these deficits. Theoretical principles of efficient 
information processing and empirical findings in single cells suggest that in order to efficiently 
represent all of the possible rewards, reward sensitive neurons adapt their coding range 
dynamically to the current reward context. A reduction in adaptive coding would affect the 
accurate representation of rewards and could potentially lie at the root of many dysfunctional 
reward processes in schizophrenia.  
 
Methods: To investigate adaptive coding in patients with schizophrenia (n=27) and healthy 
controls (n=25), we used functional magnetic resonance imaging in combination with a 
variant of the monetary incentive delay task that involved two different reward contexts, 
allowing us to study adaptive coding of reward.  
 
Results: Patients with schizophrenia did not efficiently adapt to the current reward context in 
two reward sensitive regions, the right caudate and the right anterior insula/inferior frontal 
gyrus. This inefficient adaptation led to diminished discriminability and, hence, imprecise 
neural representation particularly of small rewards. Importantly, general symptom severity 
was correlated with the deficit in reward coding adaptation.  
 
Conclusion: Our results suggest that some of the deficits in reward representations in 
schizophrenia are linked to deficient adaptive coding of reward. Due to the ubiquity of 
adaptive coding in the brain, we believe that our findings provide an avenue to defining a 
general impairment in neural information processing underlying this disorder. 
 
Key words: schizophrenia, functional magnetic resonance imaging, reward outcome, 
information-processing, dorsal striatum, anterior insula 
  
Appendix 
	 	 	 108 
 
1. Introduction 
Aberrant reward processing is thought to play a major role in the pathophysiology of 
schizophrenia (1). Negative symptoms of schizophrenia have been associated with several 
processes linked to reward processing, such as impairments in reinforcement learning (2–8), 
reward anticipation (9–12) and cost-benefit computation (13–16). On the other hand, positive 
symptoms are discussed in terms of aberrant salience coding (17–24). All these processes 
require a precise representation of reward, which is crucial for optimal decision making and 
hence for efficient interaction with a dynamic environment (25; 26). Conversely, an imprecise 
representation of reward can potentially affect all reward-related processes that are impaired 
in patients with schizophrenia and could therefore characterize a core dysfunction related to 
the illness.  
 
Reward is represented across several cortical and subcortical regions related to the 
dopaminergic system, such as the striatum, the orbitofrontal cortex, and the medial temporal 
cortices. Emerging evidence suggests that these representations are context specific, such 
that they adjust to the rewards that are available in the current context (25; 27–32). The 
dynamic adjustment in the firing of reward sensitive neurons to the current context is also 
known as adaptive coding of reward (33). This adaptation is necessary, because the coding 
range of any neuron, including reward-sensitive neurons, is limited (i.e. the firing rate can 
increase only up to some degree), whereas the diversity and range of potential inputs, 
including rewards, in our daily life is theoretically unlimited. Hence, if the full coding range 
would be devoted to represent all possible rewards, only relatively large differences in reward 
amounts could be represented and discrimination between amounts would be imprecise.  
 
An efficient solution to this problem has been characterized both for sensory and reward 
systems. It consists of adapting the sensitivity of neurons to the range of (sensory or reward) 
inputs that are most probable in the current context. As a result, the slope of the response 
function of reward coding neurons is steeper in contexts with smaller reward ranges and 
shallower in contexts with larger reward ranges (see Figure 1A) (34). Thus, adapting slopes 
ensure optimal sensitivity to currently available rewards. This mechanism allows the 
organism to discriminate between different reward amounts as much as possible, and 
thereby enables informed decision making. On the other hand, if there is no adaptation, or if 
the adaptation is inefficient, reward information cannot be fully encoded, resulting in a loss of 
information and therefore in uncertainty about the precise reward amount of a stimulus or 
action (30). This uncertainty can be caused by two different mechanisms: In case the 
response function is too narrow, amounts at the extreme end of the distribution would be 
misrepresented. On the other hand, if the response function is too wide, it would result in 
unnecessarily flat slopes with poor discrimination between different amounts (see Figure 1B). 
In summary, a lack of dynamic neural adaptation leads to uncertainty in the representation of 
reward, which might result in detrimental decision making and a failure to efficiently engage 
with the environment. 
 
Very little attention has been paid to the role of potential deficits in adaptive coding as a 
fundamental dysfunction of reward information processing in schizophrenia. To our 
knowledge, no study has investigated if dynamic neural adaptation to available rewards is 
deficient in schizophrenia. We therefore constructed a modified version of the monetary 
incentive delay task that enabled us to investigate adaptive coding of reward during the 
outcome phase. The findings for reward anticipation have been presented elsewhere (35). 
Appendix 
	 	 	 109 
 
We hypothesized that patients with schizophrenia show deficits in neural adaptation in 
reward coding regions, such as the striatum, in comparison to healthy controls. Furthermore, 
we were interested whether there is a correlation of the degree in adaptive reward coding 
with symptom severity in schizophrenia.  
 
 
2. Methods and Materials 
2.1 Participants 
We included 29 patients with schizophrenia (SZ) and 28 healthy control participants (HC). 
Participants with SZ were recruited from outpatient (n = 12) and inpatient (n = 17) units of the 
Psychiatric Hospital of the University of Zurich or from affiliated institutions. All patients with 
SZ were clinically stable and received a stable dose of medication. The project was approved 
by the local ethics committee. All participants gave written informed consent to participate in 
the study. Diagnosis of schizophrenia was confirmed in a structured Mini-International 
Neuropsychiatric Interview for DSM-IV (36). We excluded participants with any other DSM-IV 
axis I disorder, medication with lorazepam higher than 1mg, acute psychotic symptoms, i.e. 
any positive subscale item score higher than four as measured with the Positive and 
Negative Syndrome Scale (PANSS) (37), and extrapyramidal side effects, i.e. a total score 
higher than two on the Modified Simpson-Angus Scale (MSAS) (38).  
 
2.2 Clinical and Neuropsychological Assessment 
All study participants underwent an extensive psychopathological assessment. Severity of 
positive and negative symptoms was assessed with the PANSS. Additionally, negative 
symptoms were specifically assessed with the brief negative symptom scale (BNSS) (39). 
Further psychopathological assessment included the Calgary Depression Scale for 
Schizophrenia (CDSS) (40), the Global Assessment of Functioning scale (GAF) (41), and the 
Personal and Social Performance Scale (PSP) (42). Moreover, both groups performed a 
neuropsychological test battery assessing verbal learning (Auditory Verbal Learning Memory 
Test) (43), verbal and visual short-term working memory [(digit span) (44) and (Corsi block-
tapping test) (45)], processing speed (Digit-Symbol Coding) (46), planning (Tower of London) 
(47) and semantic and phonetic fluency (animal naming, s-words) (48). Results of all 
cognitive tests were summarized in a composite cognition score computed with the mean of 
z-transformed scores (based on HC group data). Additionally, we used the Multiple Word 
Test (49) to control for premorbid verbal intelligence. 
 
2.3 Experimental Design and Task 
We used a variant of the monetary incentive delay task (50) with stimuli based on the cued-
reinforcement reaction time task used by Cools et al (51). This variant enabled us to 
investigate reward anticipation and reward outcome separately. In each correct trial (Figure 
2), participants received a reward, which was determined directly by the individual response 
time. Thus, in contrast to most versions of the monetary incentive delay task, there was no 
dichotomy reward/no-reward in the outcome phase, but a continuous distribution of rewards. 
Importantly, our task included two different reward contexts, a low reward context, ranging 
from 0 to 0.4CHF, and a high reward context, ranging from 0 to 2CHF (in addition to a neutral 
control condition without reward). The differential reward range of the low and high reward 
context allowed us to investigate the dynamic adaptation of reward sensitive activation in the 
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current reward context. In particular, adaptation would correspond to a steeper slope of the 
mapping between output (response strength) and input (reward amount) for the low reward 
context compared to the high reward context (Figure 1A and below).  
 
Before starting the experiment, we informed all participants that they would receive the 
accumulated amount of money they won during the two experimental sessions. The 
maximum amount of money to be won was 50CHF. Every participant performed two training 
runs, one outside and one inside the scanner. Excluding the training sessions, the 
experiment contained two runs with 36 trials of about 10s each. The intertrial interval (ITI) 
was jittered from 1 to 9s with a mean of 3.5s. In total, one run lasted about 6min. The task 
was implemented using the MATLAB toolboxes Cogent 2000 and Cogent Graphics. 
 
2.4 Functional Imaging Data Acquisition 
Imaging data was collected with a Philips Achieva 3.0T magnetic resonance (MR) scanner 
using a 32 channel SENSE head coil (Philips, Best, The Netherlands) at the MR center at the 
Psychiatric Hospital, University of Zurich. Functional MRI (fMRI) was acquired in two runs 
with 195 ascending transverse plane images using a gradient-echo T2*-weighted echo-
planar image (EPI) sequence over the whole brain. Acquired in-plane resolution was 
3×3mm2, 3mm slice thickness and 0.5mm gap width over a field of view of 240×240mm2, a 
repetition/echo time (TR/TE) of 2000/25ms and a flip angle of 82°. The first five scans were 
discarded to eliminate the influence of T1 saturation effects. Slices were aligned with the 
anterior–posterior commissure. Anatomical data was acquired with an ultrafast gradient echo 
T1-weighted sequence in 160 sagittal plane slices of 240×240mm2 resulting in 1x1x1mm3 
voxels. 
 
2.5 Data Analysis 
All demographic, clinical, neuropsychological and behavioral data, as well as the correlations 
were analyzed using IBM SPSS Statistics Version 22. We analyzed fMRI data using SPM8 
(Statistical Parametric Mapping, Wellcome Department of Cognitive Neurology, London, UK). 
 
2.5.1 Behavioral Data 
The main behavioral outcome measure was response time, defined as time between target 
presentation and pressing the correct answer button. We performed a two-way repeated 
measures analysis of variance (ANOVA) with group as between-subject factor and reward 
condition (low, high) as within-subject factor. Potential group differences in all other 
behavioral data were investigated using two sample t-tests. For non-normally distributed data 
(as assessed by the Kolmogorov-Smirnov test), Mann-Whitney U tests were applied. 
 
2.5.2 Image Preprocessing 
Functional images were corrected for differences in the time of slice acquisition. The Realign 
and Unwarp functions of SPM8 were used to correct our data for head motion. A voxel 
displacement map, calculated from double phase and magnitude field map data, was used to 
correct for combined static and dynamic distortions. We performed segmentation, bias 
correction, and spatial normalization. Finally, images were smoothed using a Gaussian 
kernel of 6 mm width at half maximum. We evaluated the quality of fMRI data by manual 
inspection and excluded data with poor quality due to significant signal dropout in EPI 
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sequences (one patient with schizophrenia). Furthermore, participants with translational head 
movement >3mm (1 voxel size) were excluded (five participants, 3 HC, 2 SZ), leaving a total 
sample of 27 patients with schizophrenia and 25 healthy controls. 
 
2.5.3 First Level Image Analyses 
We computed a general linear model (GLM) with a parametric design to identify brain regions 
that encode reward in an adaptive fashion at the outcome phase. In particular, we modelled 
the onsets of each reward condition separately (no/low/high reward). Please note that these 
regressors accounted for potential differences in mean activation between the low (CHF 0.4) 
and the high reward condition (CHF 2.0). Importantly, the low and high reward outcome 
regressors were parametrically modulated (pmod) by the actual outcome won in each trial 
[pmod low reward, pmod high reward]. Thus, these modulators capture reward amount; 
pmod low ranged from CHF 0 to CHF 0.4, pmod high ranged from CHF 0.4 to CHF 2.0, 
resulting in a smaller range for the low reward outcomes. The anticipation phase for each 
condition, the target presentation for each condition and error trials were modeled as 
regressors of no interest. In total, the first level model included twelve regressors. The 
canonical hemodynamic response function was used for convolving all explanatory variables.  
 
2.5.4 Second Level Image Analyses – Identification of reward coding regions 
At the second level of analysis, we included the individual contrast images of all participants 
in a random-effects model. We assessed within-group activation using one sample t-tests 
and between-group activation using two sample t-tests. To identify reward coding brain 
regions, we used a contrast including both parametric modulators [pmod low + pmod high], 
which we applied in a voxel wise whole brain analysis across all participants. The statistical 
threshold was set to p≤.05, whole-brain cluster-level family-wise error (FWE) rate corrected 
for multiple comparisons, with a cluster-inducing voxel threshold of p<.001. 
 
2.5.5 Second Level Image Analyses – Adaptive coding of reward  
In a second step, we tested adaptive coding of reward within the previously identified reward 
coding brain regions. Efficient neural adaptation of reward implies that the responses 
dynamically adjust to the range of possible rewards. Therefore, the slope of the response 
function should be steeper with a smaller reward range compared to a larger reward range 
(Figure 1A). Consequently, in case of adaptive coding in our task, the slope of the response 
function in the low reward condition should be steeper than the slope in the high reward 
condition. To test for a significant difference, we therefore subtracted the parametric 
regressor of the high reward from the low reward condition [pmod low reward – pmod high 
reward]. A significant result provides strong evidence for adaptive coding, because it reflects 
significant differences in the slope of the reward response function.  
 
According to our primary hypothesis, we tested if patients with schizophrenia show deficits in 
context-dependent neural adaptation compared to healthy controls. Therefore, we computed 
group differences between healthy controls and patients with schizophrenia in the adaptive 
coding contrast [(HC (pmod low reward) – (pmod high reward)) - (SZ (pmod low reward) – 
(pmod high reward))]. Please note that this contrast is independent of the one used to 
identify the reward-related ROIs. Finally, we evaluated if efficient adaptation of reward is 
correlated with symptom severity in patients with schizophrenia. Therefore, we performed 
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bivariate Pearson correlation analyses between the adaptive coding contrast estimate 
[(pmod low reward) – (pmod high reward)] and symptom severity ratings. 
 
 
3. Results 
3.1 Sample Characteristics 
Participant demographics, clinical data and group comparisons are summarized in Table 1. 
 
3.2 Behavioral Data 
Regarding response time, the repeated measures ANOVA revealed no significant main effect 
of group [F(1, 50)=2.91, p=.09], but a significant main effect of reward condition [F(1, 
50)=36.2, p<.0001]. Across all participants, response times were faster in the high reward 
condition, indicating that participants adapted their behavior to the different reward context 
(low vs. high reward). There was no significant group by reward interaction effect 
[F(1,50)=.65, p=.47]. Due to low error rates we used a total error score for group comparison 
and did not find any group differences (HC=3.3 (2.5); SZ=3.8 (2.8.); U=315, p=.68). Finally, 
both groups differed significantly in total win (HC=38.9 (5.2); SZ=36 (4.6); t=2.1, p=.04), 
although the differences were small. 
 
3.3 fMRI Data 
3.3.1 Brain regions coding reward  
Voxel-wise whole brain analysis across all subjects during reward outcome [pmod low 
reward + pmod high reward] revealed several brain regions coding for reward (cluster-level 
FWE-corrected, p≤.05), i.e. the ventral and dorsal striatum, medial orbitofrontal cortex and 
anterior insula/inferior frontal gyrus (see Table 2). Thus, activation in these regions increases 
with reward amount at the time of outcome. 
 
3.3.2 Group differences in adaptive coding of reward  
Within these reward sensitive regions, we tested for group differences in adaptive coding 
between healthy controls and patients with SZ. Specifically, we compared the slope 
differences in the reward response functions for low and high reward [(HC (pmod low reward) 
– (pmod high reward)) - (SZ (pmod low reward) – (pmod high reward))]. In the dorsal striatum 
(x=21, y=3, z=22; cluster size=19, t=4.7, FWE corrected p≤.05, Figure 3A) and the anterior 
insula/inferior frontal gyrus (x=50, y=-4, z=6; cluster size=24, t=5.43, FWE corrected p≤.05, 
Figure 3B), healthy controls showed significantly stronger adaptive coding [pmod low reward 
– pmod high reward] relative to patients with schizophrenia. Additionally, results were similar 
when we used an anatomically defined ROI of the striatum defined with the wfu pickatlas 
SPM8 (right: x=23, y=2, z=21, cluster size=39; left: x=-6, y=14, z=12, cluster size=8, both 
FWE corrected p≤.05). These findings imply significant differences between the slope of the 
response function in the low reward and high reward condition in healthy controls, but not in 
patients with schizophrenia. In other words, these significant group differences provide 
strong evidence for efficient neural adaptation of reward coding in the dorsal striatum and 
anterior insula/inferior frontal gyrus in healthy controls, but not in the patient group. To 
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visualize these differences in the adaptive coding of reward, we plotted the response 
functions of the neural activity in the low and high reward condition separately (Figure 4).  
 
Next, we tested whether there are any clusters in the reward sensitive regions where patients 
with schizophrenia show more efficient adaptive coding of reward than healthy controls [(SZ 
(pmod low reward) – pmod high reward)) – (HC (pmod low reward) – (pmod high reward))]. 
In this analysis we did not find any significant activation at the previously used more stringent 
threshold (FWE corrected, p≤.05) and only one single voxel at a more lenient threshold 
(p<.001, uncorrected). 
 
3.4 Correlation Analysis 
Correlation analysis between adaptive coding contrast estimates [(pmod low reward) – 
(pmod high reward)] in the right caudate and symptom severity rated with the PANSS total 
score (r=-.56, p<.01) revealed a highly significant negative correlation in the patient group 
(Figure 5). Importantly, this effect was also present for positive symptoms (PANSS positive 
symptom score; r=-50, p<.01), negative symptoms (PANSS negative symptom score; r=-.45, 
p=.02) and general symptoms (PANSS general symptom score; r=-.47, p=.01). Furthermore, 
we found a trend effect with the BNSS total score (r=-.37, p=.06) in the patient group.  There 
were no significant correlations with the two negative symptom factors apathy (r=-.30, p=.12) 
and diminished expression (r=-.32, p=.10). Potential confounding variables such as 
chlorpromazine equivalents (r=-.04, p=.85) or cognition (composite cognition score; r=-.13, 
p=.51) showed no significant association with deficient adaptive coding of reward. In sum, 
higher symptom severity was associated with less adaptive coding in the caudate. 
 
The correlation analysis between adaptive coding contrast estimates [(pmod low reward) – 
(pmod high reward)] in the anterior insula/inferior gyrus and symptom severity, measured 
with the PANSS total score yielded a negative trend level correlation (r=-.34, p=.08) and no 
significant correlation with the BNSS (r=-.05, p=.80).  
 
 
4. Discussion 
In the current study, we used a modified version of the monetary incentive delay paradigm to 
investigate adaptive reward coding for the first time in patients with schizophrenia. We found 
that patients with schizophrenia show inefficient adaptive coding in two reward sensitive 
regions, namely in the right caudate and the right anterior insula/inferior frontal gyrus. These 
findings imply that patients with schizophrenia are not able to precisely represent reward 
information within these two regions due to a failure to adjust neural sensitivity to the 
available rewards. Furthermore, we could show that the deficit in adaptive coding is related 
to the total symptom severity of patients with schizophrenia. This was the case particularly 
for the right caudate, where we found a significant negative correlation of the adaptive coding 
deficits with the PANSS total score and with the PANSS subscales. Overall, these findings 
suggest that patients with schizophrenia have deficits in adaptive coding of rewards due to a 
diminished discriminability of different reward amounts. This decreased sensitivity leads to an 
imprecise representation of reward information.  
 
The significant deficits in adaptive coding of patients diagnosed with schizophrenia relative to 
healthy controls were found in two reward sensitive regions - the right caudate and the right 
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AI/IFG. In the right caudate, patients only exploit a fraction of the response range to 
represent reward information compared to healthy controls, which impairs discriminability 
between different reward amounts. The caudate, together with the putamen, forms the dorsal 
part of the striatum, which is involved in learning about actions and their reward 
consequences as well as the selection of actions based on the reward they are associated 
with (52–55). Our findings of an adaptive coding deficit is in line with work by Morris and 
colleagues (56) who recently described an association of caudate dysfunction with an 
impairment in integrating changes in experienced reward values (devaluation of food 
rewards) to guide choice behavior in patients with schizophrenia.  
 
In the AI/IFG, adaptive coding in the low reward condition was so disrupted in patients that 
reward amount was no longer encoded with a positive slope. However, reward amount in the 
high reward condition was encoded similarly to healthy controls, suggesting partly preserved 
sensitivity to reward. The observed deficits in adaptive coding in the anterior insula and the 
related structure of the IFG are in line with aberrant salience processing observed in 
schizophrenia (57–60). Specifically, the imprecise neural representation of reward 
information could lead to increased uncertainty about external stimuli or internal values, 
which in turn may alter the processing of what is important. In support of this notion, Anselme 
and colleagues recently reported that reward uncertainty enhances salience attribution (61). 
 
We found that patients with schizophrenia show poorer neural discrimination of different 
rewards. This inefficient adaptation results in an imprecise encoding of reward information, 
which has potentially far-reaching consequences. It can affect all reward related processes 
and hence severely impinge on an organism’s ability to optimally interact with its 
environment. Several studies have already reported that patients with schizophrenia have 
difficulties in reward representations. Gold et al. (3) found a correlation of negative symptoms 
with a deficit in learning from rewarding outcomes. They suggested that this deficit is related 
to impairment in the representation of value. Gold et al. (14) and Hartmann et al. (15) both 
report that impairments in effort based decision making in schizophrenia might be related to 
alterations in value representations. For the first time, we could show that deficits in reward 
representation can result from an inefficient adaptation of neural sensitivity to the current 
reward context.  
 
Our findings expand the current understanding of reward processing deficits in schizophrenia 
substantially by introducing a new concept – the contextual adaptation of neural sensitivity to 
reward. Furthermore, we could show that the deficit in adaptive coding is related to total 
symptom severity. This suggests that the deficit in adaptive coding of reward could reflect a 
more basic dysfunction instead of a specific neural correlate of positive, negative, or 
depressive symptoms (1; 62–64). Here, it is important to consider that context-dependent 
adaptation of neural activity does not solely apply to the encoding of reward information, but 
also to sensory information processing, i.e., the processing of auditory and visual information 
(65; 66). Although speculative, such a general deficit in context-dependent adaptation might 
contribute to a better understanding of deficits in sensory information-processing observed in 
patients with schizophrenia (24; 67; 68). Furthermore, earlier studies have proposed that the 
“core” cognitive deficit in schizophrenia is a disturbance of context information processing 
(69–71). However, to support this hypothesis of a general underlying deficit, further studies 
elucidating context-dependent neural adaptation in other domains, such as sensory and 
cognitive information processing, are needed. 
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Some limitations of this study are worth mentioning. Although in our analysis, we did not find 
any statistical effect of antipsychotic medication, we cannot fully exclude potential 
confounding effects due to atypical antipsychotics. Therefore, it would be important to 
investigate whether our findings can be generalized to antipsychotic naïve patients and 
patients with first generation antipsychotics. Furthermore, our sample showed relatively low 
levels of positive and depressive symptoms, which limits the possibility to differentiate 
specific effects of these domains. Thus, further research is needed to clarify whether the 
impairment in adaptive coding is indeed a general disturbance associated with 
schizophrenia. Lastly, it has to be mentioned that due to the task design, it is difficult to 
precisely disentangle whether the observed changes in adaptive outcome coding reflect 
disturbances in the processing of experienced reward or of a reward prediction error (i.e. the 
difference between predicted and experienced reward).  
 
In summary, the present findings provide the first evidence that patients with schizophrenia 
show inefficient adaptive coding of reward. This deficit causes an imprecise representation of 
reward information due to diminished discriminability of different reward amounts. At a 
behavioral level, this basic information-processing deficit may be partly responsible for 
impaired reinforcement learning, deficits in cost-benefit computations and aberrant salience 
coding. This broad potential impact on reward-related processes would be in line with the 
observation that the adaptive coding deficit is related to total symptom severity. We believe 
that this finding not only contributes to a better understanding of the reward processing 
deficits in schizophrenia, but – due to the ubiquity of this process – suggests an approach to 
identify a general impairment in neural mechanisms underlying this debilitating disorder.   
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Tables 
Table 1 	
 Patient Group 
(n = 27) 
Healthy Controls 
(n = 25) 
Test Statistic 
(t/Χ2/U) 
 
P 
Age 31.9 (7.1) 33.0 (9.7) U = 322.00 .78 
Gender (female/male) 9/18 9/16 Χ2 = .04 .81 
Education in years 12.2 (3.0) 12.4 (3.6) U = 334.00 .95 
Duration of illness in years 9.2 (6.6) − − − 
Age of onset in years  22.7 (6) − − − 
Chlorpromazine equivalents (mg/d) 491.3 (349.5) − − − 
Psychopathology     
 PANSS positive  11.2 (2.9) − − − 
 PANSS negative 14.7 (5.8) − − − 
 PANSS general psychopathology 23.5 (4.8) − − − 
 PANSS total 49.4 (11.2) − − − 
 BNSS apathya 14.8 (6.9) − − − 
 BNSS diminished expressionb 8.5 (7.2) − − − 
 BNSS total 24.6 (12.4) − − − 
 CDSS Total 1.6 (2.2) − − − 
 GAF 56.9 (9.6) − − − 
 PSP Total 56.4 (9.9) − − − 
Cognitionc     
 Composite cognition score -.62 (.89) 0 (.53) t = 3.0 .01 
 MWT IQ 25.9 (5.8) 27.6 (4.0) t = 1.2 .23 
Note: Data are presented as means and standard deviations. Potential group differences were 
investigated using 2-sample t tests for continuous and chi-square tests for categorical data. For 
non-normally distributed data Mann-Whitney U tests were applied. All patients were receiving 
atypical antipsychotics at the time of testing. PANSS, Positive and Negative Syndrome Scale; 
BNSS, Brief Negative Symptom Scale; SANS, Scale for the Assessment of Negative Symptoms; 
CDSS, Calgary Depression Scale for Schizophrenia; GAF, Global Assessment of Functioning; 
PSP, Personal and Social Performance Scale; MWT IQ, Multiple Word Test Intelligence 
Quotient. 
 
a Apathy = Avolition, Anhedonia, Asociality; b Diminished Expression = Affective Flattening or 
Blunting, Alogia. 
 
c Cognition data were z-transformed based on the data of the HC group for each test separately. 
The Composite cognition score was computed as the mean of the z-transformed test scores on 
subject level. 
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Table 2 	
 X Y Z Cluster Size t 
Middle frontal gyrus -24 24 52 1780 6.29 
 -17 18 61  5.44 
 -22 43 25  5.43 
Inferior parietal lobe -46 -63 40 7494 6.29 
 16 -88 25  6.07 
 6 -75 24  5.70 
Dorsal Striatum 25 -31 28 3062 6.07 
 30 -18 28.5  5.35 
 16 -33 69  5.33 
Insula/ inferior frontal 
gyrus 
60 3 12 657 5.84 
 31 -6 3  5.80 
 39 -4 10  4.38 
Putamen left -21 6 -10 1300 5.5 
 -9 24 -16  5.1 
 -23 12 -2  5.0 
Putamen right 23 6 -10 685 5.4 
 8 23 -11  4.5 
 14 21 -2  4.3 
mOFC -8 54 -6 267 5.0 
 -3 62 1  4.2 
Postcentral gyrus left -26 -36 73 781 4.8 
 -24 -28 54  4.4 
 -22 -30 67  4.4 
Paracentral gyrus 5 -31 61 830 4.7 
 -2 -43 60  4.4 
 -6 -40 51  4.3 
Whole brain analysis of the contrast reward outcome [pmodLow + pmodHigh 
Reward], family wise error corrected (FWE) p<.05, across all subjects. 
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Figures 
Figure 1 
 
 
 
Figure Legend: 
A) A simple model of adaptive coding of reward. To efficiently encode all possible rewards 
with a limited coding range, the brain is dynamically adjusting the response sensitivity to the 
currently available rewards. This mechanism allows to optimally discriminate between 
different amounts of reward in any given context, enabling efficient processing of reward 
information. B) Contrast of optimal and disturbed adaptive coding. This plot illustrates two 
potential consequences of inefficient adaptation of the coding range. Response function a) is 
too steep, leading to a miscoding/incomplete representation of reward information. Response 
function c) is too shallow, which leads to poor discriminability of reward due to a restricted 
coding range. Response function b) shows optimal adaptive reward coding, where the slope 
of the response function adapts so as to represent the full range of reward. 
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Figure 2 
 
 
 
Figure Legend: 
Adapted monetary incentive delay task: At the beginning of each trial, one of three different 
cues was presented for 0.75s. The cue indicated the reward context, specifically the range of 
possible amounts participants could gain in that trial, i.e. 0 to 2 Swiss Francs (CHF) (circle 
with two lines), 0 to 0.40CHF (circle with one line), or 0CHF (circle only) (1CHF = 1.08US $). 
After a delay, varying from 2.5 to 3s, the participants had to identify an outlier from three 
presented circles and press a button (either left or right) as fast as possible (varying from 
0.32 to 1s). In case of a correct answer, participants were immediately notified of the amount 
of money they had won, which directly depended on their individual task performance 
(duration of feedback 2s). The gain of each trial was calculated based on the response times 
of the previous 15 individual trials. Error trials were defined as trials with a wrong response or 
late response (after 1s) and participants did not receive any monetary reward.  
  
Appendix 
	 	 	 126 
 
Figure 3 
 
 
 
Figure Legend: 
Brain regions responding to reward amount and showing differential adaptive coding. 
Reward responses [(pmod low reward) + (pmod high reward)] are colored in blue. Colored in 
red are clusters where healthy controls showed significantly stronger activation increases in 
the adaptive coding contrast [(pmod low reward) – (pmod high reward)]. Brain images 
thresholded at p<.05 (FWE). (A) Axial image in the right caudate. (B) Axial image of the right 
insula/IFG. Columns in bar graphs illustrate red clusters and reflect adaptive coding contrast 
estimates [(pmod low reward) – (pmod high reward)] for each group separately. 
  
Appendix 
	 	 	 127 
 
Figure 4 
 
 
Figure Legend: 
Response functions in the right caudate (Figure 4A) and the right anterior insula/inferior 
frontal gyrus (Figure 4B) plotted separately for the low reward (blue) and the high reward 
(red) context. Healthy controls optimally adapt the coding range to the current range of 
rewards in both regions, resulting in a steeper slope of neural responses in the low reward 
context than in the high reward context (figures 4A and 4B left). In contrast, patients with 
schizophrenia show significant deficits in adaptive coding, with insufficient slope increase 
(caudate; figure 4A right) or even shallower slope (insula; figure 4B right) for the low reward 
context compared to the high reward context. The diminished steepness of slopes translates 
to reduced discriminability in both reward contexts for the right caudate of patients. By 
contrast, in the right AI/IFG, discriminability was reduced primarily in the low reward context, 
whereas it was comparable to the discriminability of healthy controls in the high reward 
context.  
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Figure 5 
 
 
 
Figure Legend: 
Correlation plots of the adaptive coding contrast estimates with the PANSS total score in 
patients with schizophrenia. In the right caudate, we found a significant negative correlation 
of the degree of adaptive coding with the PANSS total score. 
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